IL-2	B-protein
-independent	O
activation	O
and	O
proliferation	O
in	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
induced	O
by	O
CD28	B-protein
.	O

Although	O
the	O
role	O
of	O
CD28	B-protein
in	O
T	O
cell	O
costimulation	O
is	O
firmly	O
established	O
,	O
the	O
mechanisms	O
by	O
which	O
it	O
exerts	O
its	O
costimulatory	O
actions	O
are	O
less	O
clear	O
.	O

In	O
many	O
circumstances	O
it	O
is	O
difficult	O
to	O
distinguish	O
the	O
effects	O
of	O
CD28	B-protein
from	O
subsequent	O
actions	O
of	O
cytokines	B-protein
,	O
such	O
as	O
IL-2	B-protein
,	O
on	O
T	O
cell	O
proliferation	O
.	O

Here	O
,	O
we	O
report	O
a	O
model	O
of	O
CD28	B-protein
costimulation	O
using	O
PMA	O
plus	O
the	O
natural	B-protein
ligand	I-protein
CD80	I-protein
that	O
resulted	O
in	O
very	O
limited	O
stimulation	O
of	O
IL-2	B-protein
,	O
as	O
evidenced	O
by	O
both	O
cytokine	B-protein
production	O
and	O
IL-2	B-DNA
promoter	I-DNA
stimulation	O
.	O

Promoter	O
assays	O
revealed	O
CD28	B-protein
-dependent	O
effects	O
on	O
both	O
NF-kappaB	B-protein
and	O
AP-1	B-protein
,	O
but	O
not	O
on	O
NF-AT	B-protein
or	O
the	O
intact	O
IL-2	B-DNA
promoter	I-DNA
.	O

In	O
addition	O
,	O
T	O
cell	O
proliferation	O
was	O
completely	O
resistant	O
to	O
the	O
actions	O
of	O
the	O
immunosuppressant	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
.	O

Moreover	O
T	O
cell	O
proliferation	O
was	O
unaffected	O
by	O
the	O
addition	O
of	O
blocking	O
Abs	B-protein
to	O
both	O
IL-2	B-protein
and	O
the	O
IL-2	B-protein
receptor	I-protein
,	O
demonstrating	O
that	O
this	O
form	O
of	O
costimulation	O
by	O
CD28	B-protein
was	O
independent	O
of	O
IL-2	B-protein
.	O

We	O
also	O
investigated	O
the	O
effects	O
of	O
stimulating	O
T	B-cell_type
cell	I-cell_type
blasts	I-cell_type
with	O
CD80	B-protein
alone	O
and	O
found	O
that	O
there	O
was	O
a	O
limited	O
requirement	O
for	O
IL-2	B-protein
in	O
this	O
system	O
.	O

We	O
conclude	O
that	O
CD28	B-protein
costimulation	O
can	O
cause	O
substantial	O
T	O
cell	O
proliferation	O
in	O
the	O
absence	O
of	O
IL-2	B-protein
,	O
which	O
is	O
driven	O
by	O
a	O
soluble	B-protein
factor	I-protein
independent	O
of	O
NF-AT	B-protein
transactivation	O
.	O

Flexible	NULL
,	NULL
Intuitive	NULL
,	NULL
and	NULL
Luminex	NULL
.	NULL

C4	NULL
-	NULL
«	NULL
gf\	NULL
_	NULL
}	NULL
Affordable	NULL
Cytometry	NULL
,	NULL
warmmore	NULL
complexity	NULL
simplified	NULL
.	NULL

Guava®	NULL
easyCyte	NULL
``	NULL
Flow	NULL
Cytometers	NULL
.	NULL

Ln	NULL
mJournal	NULL
f	NULL
IL-2-Independent	NULL
Activation	NULL
and	NULL
4D	NULL
Imnmunolo	NULL
gy	NULL
Proliferation	NULL
in	NULL
Human	NULL
T	NULL
Cells	NULL
Induced	NULL
by	NULL
CD28	NULL
This	NULL
inf	NULL
tion	NULL
i	NULL
t	NULL
George	NULL
Boulougouris	NULL
,	NULL
Julie	NULL
D.	NULL
McLeod	NULL
,	NULL
Yusuf	NULL
I.	NULL
Patel	NULL
,	NULL
of	NULL
£1	NULL
:	NULL
le	NULL
ggngoli	NULL
)	NULL
;	NULL
Is	NULL
current	NULL
as	NULL
Claire	NULL
N.	NULL
Ellwood	NULL
,	NULL
Lucy	NULL
S.	NULL
K.	NULL
Walker	NULL
and	NULL
David	NULL
M.	NULL
Sansom	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
163:1809-1816	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/4/1809	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
39	NULL
articles	NULL
,	NULL
19	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/4/1809.full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

IL-2-Independent	NULL
Activation	NULL
and	NULL
Proliferation	NULL
in	NULL
Human	NULL
T	NULL
Cells	NULL
Induced	NULL
by	NULL
CD28	NULL
!	NULL

George	NULL
Boulougouris	NULL
,	NULL
Julie	NULL
D.	NULL
McLeod	NULL
,	NULL
Yusuf	NULL
I.	NULL
Patel	NULL
,	NULL
Claire	NULL
N.	NULL
Ellwood	NULL
,	NULL
Lucy	NULL
S.	NULL
K.	NULL
Walker	NULL
,	NULL
and	NULL
David	NULL
M.	NULL
Sansom	NULL
Although	NULL
the	NULL
role	NULL
of	NULL
CD28	NULL
in	NULL
T	NULL
cell	NULL
costimulation	NULL
is	NULL
firmly	NULL
established	NULL
,	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
it	NULL
exerts	NULL
its	NULL
costimulatory	NULL
actions	NULL
are	NULL
less	NULL
clear	NULL
.	NULL

In	NULL
many	NULL
circumstances	NULL
it	NULL
is	NULL
difficult	NULL
to	NULL
distinguish	NULL
the	NULL
effects	NULL
of	NULL
CD28	NULL
from	NULL
subsequent	NULL
actions	NULL
of	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
on	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
report	NULL
a	NULL
model	NULL
of	NULL
CD28	NULL
costimulation	NULL
using	NULL
PMA	NULL
plus	NULL
the	NULL
natural	NULL
ligand	NULL
CD80	NULL
that	NULL
resulted	NULL
in	NULL
very	NULL
limited	NULL
stimulation	NULL
of	NULL
IL-2	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
both	NULL
cytokine	NULL
production	NULL
and	NULL
IL-2	NULL
promoter	NULL
stimulation	NULL
.	NULL

Promoter	NULL
assays	NULL
revealed	NULL
CD28-dependent	NULL
effects	NULL
on	NULL
both	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
,	NULL
but	NULL
not	NULL
on	NULL
NF-AT	NULL
or	NULL
the	NULL
intact	NULL
IL-2	NULL
promoter	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
T	NULL
cell	NULL
proliferation	NULL
was	NULL
completely	NULL
resistant	NULL
to	NULL
the	NULL
actions	NULL
of	NULL
the	NULL
immunosuppressant	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
.	NULL

Moreover	NULL
T	NULL
cell	NULL
proliferation	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
blocking	NULL
Abs	NULL
to	NULL
both	NULL
IL-2	NULL
and	NULL
the	NULL
IL-2	NULL
receptor	NULL
,	NULL
demonstrating	NULL
that	NULL
this	NULL
form	NULL
of	NULL
costimulation	NULL
by	NULL
CD28	NULL
was	NULL
independent	NULL
of	NULL
IL-2	NULL
.	NULL

We	NULL
also	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
stimulating	NULL
T	NULL
cell	NULL
blasts	NULL
with	NULL
CD80	NULL
alone	NULL
and	NULL
found	NULL
that	NULL
there	NULL
was	NULL
a	NULL
limited	NULL
requirement	NULL
for	NULL
IL-2	NULL
in	NULL
this	NULL
system	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
CD28	NULL
costimulation	NULL
can	NULL
cause	NULL
substantial	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
,	NULL
which	NULL
is	NULL
driven	NULL
by	NULL
a	NULL
soluble	NULL
factor	NULL
independent	NULL
of	NULL
NF-AT	NULL
transactivation	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
163	NULL
;	NULL
1809-1816	NULL
.	NULL

TCR	NULL
by	NULL
foreign	NULL
Ags	NULL
in	NULL
complex	NULL
with	NULL
MHC	NULL
molecules	NULL
,	NULL
other	NULL
pathways	NULL
are	NULL
important	NULL
for	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

These	NULL
pathways	NULL
include	NULL
the	NULL
delivery	NULL
of	NULL
costimulation	NULL
through	NULL
the	NULL
CD28	NULL
receptor	NULL
as	NULL
well	NULL
as	NULL
the	NULL
subsequent	NULL
production	NULL
of	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
and	NULL
signals	NULL
through	NULL
the	NULL
IL-2	NULL
receptor	NULL
.	NULL

Studies	NULL
using	NULL
mice	NULL
deficient	NULL
for	NULL
CD28	NULL
and	NULL
IL-2	NULL
demonstrate	NULL
a	NULL
number	NULL
of	NULL
defects	NULL
reflecting	NULL
the	NULL
importance	NULL
of	NULL
these	NULL
receptors	NULL
to	NULL
both	NULL
T	NULL
cell	NULL
and	NULL
B	NULL
cell	NULL
immune	NULL
responses	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Intriguingly	NULL
,	NULL
however	NULL
,	NULL
rather	NULL
than	NULL
the	NULL
predicted	NULL
immunodeficient	NULL
phenotype	NULL
,	NULL
IL-2-deficient	NULL
mice	NULL
suffer	NULL
from	NULL
T	NULL
cell	NULL
lymphoproliferation	NULL
and	NULL
a	NULL
syndrome	NULL
reminiscent	NULL
of	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
(	NULL
2	NULL
)	NULL
.	NULL

This	NULL
clearly	NULL
indicates	NULL
that	NULL
cytokines	NULL
other	NULL
than	NULL
IL-2	NULL
may	NULL
be	NULL
important	NULL
in	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

CD28	NULL
is	NULL
a	NULL
surface	NULL
glycoprotein	NULL
expressed	NULL
on	NULL
the	NULL
majority	NULL
of	NULL
T	NULL
cells	NULL
that	NULL
interacts	NULL
with	NULL
two	NULL
known	NULL
natural	NULL
ligands	NULL
(	NULL
CD80	NULL
and	NULL
CD86	NULL
)	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Both	NULL
ligands	NULL
are	NULL
expressed	NULL
by	NULL
professional	NULL
APCs	NULL
,	NULL
and	NULL
both	NULL
are	NULL
capable	NULL
of	NULL
costimulating	NULL
responses	NULL
via	NULL
CD28	NULL
.	NULL

One	NULL
of	NULL
the	NULL
most	NULL
striking	NULL
features	NULL
associated	NULL
with	NULL
CD28	NULL
costimulation	NULL
is	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
pathway	NULL
to	NULL
prevent	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
tolerant	NULL
state	NULL
known	NULL
as	NULL
T	NULL
cell	NULL
anergy	NULL
,	NULL
an	NULL
ability	NULL
closely	NULL
linked	NULL
with	NULL
the	NULL
induction	NULL
and	NULL
secretion	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cytokines	NULL
(	NULL
3-6	NULL
)	NULL
,	NULL
of	NULL
which	NULL
IL-2	NULL
ap-	NULL
I	NULL
n	NULL
addition	NULL
to	NULL
signals	NULL
initiated	NULL
following	NULL
engagement	NULL
of	NULL
the	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
University	NULL
of	NULL
Bath	NULL
,	NULL
Bath	NULL
,	NULL
United	NULL
Kingdom	NULL
;	NULL
and	NULL
Bath	NULL
Institute	NULL
for	NULL
Rheumatic	NULL
Diseases	NULL
,	NULL
Bath	NULL
,	NULL
United	NULL
Kingdom	NULL
Received	NULL
for	NULL
publication	NULL
October	NULL
22	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
June	NULL
2	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
Yamanouchi	NULL
Research	NULL
Studentship	NULL
(	NULL
to	NULL
G.B	NULL
.	NULL
)	NULL

and	NULL
by	NULL
the	NULL
Wellcome	NULL
Trust	NULL
(	NULL
J.D.M	NULL
.	NULL

,	NULL
Y.LP	NULL
.	NULL

,	NULL
and	NULL
L.S.K.W	NULL
.	NULL
)	NULL

and	NULL
the	NULL
Arthritis	NULL
Research	NULL
Campaign	NULL
(	NULL
D.M.S	NULL
.	NULL

and	NULL
C.N.E	NULL
.	NULL
)	NULL

.	NULL

D.M.S	NULL
.	NULL

is	NULL
an	NULL
Arthritis	NULL
Research	NULL
Campaign	NULL
Senior	NULL
Research	NULL
Fellow	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
David	NULL
M.	NULL
Sansom	NULL
,	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
University	NULL
of	NULL
Bath	NULL
,	NULL
Bath	NULL
,	NULL
BAZ	NULL
7AY	NULL
,	NULL
U.K.	NULL
E-mail	NULL
address	NULL
:	NULL
predms	NULL
@	NULL
bath.ac.uk	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
PI3K	NULL
,	NULL
phosphoinositide-3-kinase	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
CHO	NULL
,	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
;	NULL
iono	NULL
,	NULL
ionomycin	NULL
;	NULL
CFSE	NULL
,	NULL
carboxy	NULL
fluorescein	NULL
diacetate	NULL
succinimidyl	NULL
ester	NULL
;	NULL
P	NULL
+	NULL
I	NULL
,	NULL
PMA	NULL
+	NULL
fonomycin	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
pears	NULL
to	NULL
be	NULL
the	NULL
most	NULL
important	NULL
.	NULL

One	NULL
interpretation	NULL
is	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
costimulation	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
prevention	NULL
of	NULL
anergy	NULL
by	NULL
CD28	NULL
is	NULL
mediated	NULL
largely	NULL
by	NULL
IL-2	NULL
production	NULL
and	NULL
that	NULL
IL-2	NULL
is	NULL
responsible	NULL
for	NULL
many	NULL
CD28	NULL
effects	NULL
.	NULL

A	NULL
major	NULL
feature	NULL
of	NULL
signals	NULL
initiated	NULL
by	NULL
CD28	NULL
costimulation	NULL
is	NULL
the	NULL
resistance	NULL
of	NULL
this	NULL
pathway	NULL
to	NULL
the	NULL
calcineurin	NULL
inhibitor	NULL
,	NULL
CsA	NULL
,	NULL
although	NULL
the	NULL
degree	NULL
of	NULL
resistance	NULL
observed	NULL
has	NULL
been	NULL
variable	NULL
.	NULL

This	NULL
may	NULL
relate	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
Abs	NULL
to	NULL
CD28	NULL
can	NULL
generate	NULL
a	NULL
calcium	NULL
signal	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
that	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
degree	NULL
of	NULL
cross-linking	NULL
,	NULL
which	NULL
then	NULL
leads	NULL
to	NULL
an	NULL
apparently	NULL
CsA-sensitive	NULL
signal	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
natural	NULL
ligands	NULL
do	NULL
not	NULL
stimulate	NULL
calcium	NULL
elevation	NULL
.	NULL

Whether	NULL
or	NULL
not	NULL
CD28	NULL
is	NULL
sensitive	NULL
to	NULL
CsA	NULL
has	NULL
considerable	NULL
implications	NULL
for	NULL
the	NULL
interpretation	NULL
of	NULL
costimulatory	NULL
signals	NULL
,	NULL
since	NULL
CsA	NULL
is	NULL
known	NULL
to	NULL
inhibit	NULL
nuclear	NULL
entry	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-AT	NULL
that	NULL
is	NULL
required	NULL
for	NULL
IL-2	NULL
gene	NULL
transcription	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
if	NULL
CD28	NULL
signals	NULL
are	NULL
resistant	NULL
to	NULL
CsA	NULL
,	NULL
this	NULL
would	NULL
suggest	NULL
that	NULL
CD28	NULL
has	NULL
either	NULL
NF-AT-independent	NULL
effects	NULL
on	NULL
IL-2	NULL
production	NULL
,	NULL
or	NULL
IL-2-independent	NULL
costimulatory	NULL
functions	NULL
that	NULL
would	NULL
therefore	NULL
dissociate	NULL
CD28	NULL
costimulation	NULL
from	NULL
the	NULL
effects	NULL
of	NULL
IL-2-driven	NULL
proliferation	NULL
.	NULL

Attempts	NULL
to	NULL
understand	NULL
the	NULL
signaling	NULL
mechanisms	NULL
of	NULL
CD28	NULL
have	NULL
identified	NULL
several	NULL
pathways	NULL
,	NULL
including	NULL
activation	NULL
and	NULL
recruitment	NULL
of	NULL
the	NULL
enzyme	NULL
phosphoinositide-3-kinase	NULL
(	NULL
PI3K	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
pathway	NULL
via	NULL
acidic	NULL
sphingomyelinase	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
these	NULL
pathways	NULL
in	NULL
costimulation	NULL
of	NULL
IL-2	NULL
production	NULL
is	NULL
still	NULL
unclear	NULL
(	NULL
11	NULL
,	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Downstream	NULL
of	NULL
PI3K	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
CD28	NULL
stimulation	NULL
include	NULL
activation	NULL
of	NULL
the	NULL
ser/thr	NULL
kinase	NULL
protein	NULL
kinase	NULL
B	NULL
(	NULL
PKB	NULL
)	NULL
and	NULL
subsequently	NULL
p7086	NULL
kinase	NULL
(	NULL
15-17	NULL
)	NULL
indicating	NULL
a	NULL
possible	NULL
role	NULL
for	NULL
PI3K	NULL
in	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
PI3K	NULL
pathway	NULL
also	NULL
appears	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
CD28	NULL
receptor	NULL
recycling	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
CD28	NULL
costimulation	NULL
has	NULL
other	NULL
functions	NULL
,	NULL
such	NULL
as	NULL
protection	NULL
from	NULL
cell	NULL
death	NULL
and	NULL
increasing	NULL
longevity	NULL
of	NULL
T	NULL
cell	NULL
responses	NULL
(	NULL
19-22	NULL
)	NULL
.	NULL

CD28	NULL
costimulatory	NULL
signals	NULL
are	NULL
also	NULL
thought	NULL
to	NULL
converge	NULL
with	NULL
signals	NULL
from	NULL
the	NULL
TCR	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
(	NULL
23	NULL
)	NULL
.	NULL

This	NULL
,	NULL
along	NULL
with	NULL
the	NULL
influence	NULL
of	NULL
transcription	NULL
factors	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NF-AT	NULL
,	NULL
provides	NULL
the	NULL
basis	NULL
for	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
1810	NULL
transcriptional	NULL
activation	NULL
of	NULL
IL-2	NULL
gene	NULL
transcription	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Conse-quently	NULL
,	NULL
much	NULL
of	NULL
the	NULL
interpretation	NULL
of	NULL
CD28	NULL
costimulation	NULL
has	NULL
been	NULL
based	NULL
on	NULL
analysis	NULL
of	NULL
IL-2	NULL
transcription	NULL
and	NULL
production	NULL
.	NULL

To	NULL
address	NULL
the	NULL
role	NULL
of	NULL
IL-2	NULL
production	NULL
as	NULL
a	NULL
component	NULL
of	NULL
CD28	NULL
costimulation	NULL
and	NULL
to	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
CsA	NULL
on	NULL
CD28	NULL
responses	NULL
triggered	NULL
by	NULL
the	NULL
natural	NULL
ligand	NULL
CD80	NULL
,	NULL
we	NULL
compared	NULL
two	NULL
distinct	NULL
T	NULL
cell	NULL
stimulation	NULL
protocols	NULL
,	NULL
using	NULL
either	NULL
PMA	NULL
and	NULL
ionomycin	NULL
or	NULL
PMA	NULL
plus	NULL
CD80	NULL
ligand	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
stimulate	NULL
T	NULL
cells	NULL
and	NULL
support	NULL
IL-2	NULL
production	NULL
.	NULL

These	NULL
experiments	NULL
revealed	NULL
that	NULL
T	NULL
cells	NULL
proliferated	NULL
strongly	NULL
to	NULL
both	NULL
stimuli	NULL
;	NULL
however	NULL
,	NULL
PMA	NULL
plus	NULL
CD8O-stimulated	NULL
proliferation	NULL
occurred	NULL
in	NULL
a	NULL
completely	NULL
CsA-resistant	NULL
fashion	NULL
whereas	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
was	NULL
sensitive	NULL
to	NULL
CsA	NULL
.	NULL

Strikingly	NULL
,	NULL
irrespective	NULL
of	NULL
whether	NULL
CsA	NULL
was	NULL
used	NULL
,	NULL
PMA-	NULL
and	NULL
CD8O-stimulated	NULL
cells	NULL
displayed	NULL
a	NULL
highly	NULL
impaired	NULL
ability	NULL
to	NULL
produce	NULL
IL-2	NULL
,	NULL
and	NULL
,	NULL
using	NULL
neutralizing	NULL
Abs	NULL
to	NULL
IL-2	NULL
and	NULL
IL-2	NULL
receptor	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
proliferation	NULL
was	NULL
independent	NULL
of	NULL
IL-2	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
studies	NULL
on	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
indicated	NULL
that	NULL
PMA	NULL
plus	NULL
CD80	NULL
could	NULL
stimulate	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
elements	NULL
,	NULL
but	NULL
not	NULL
NF-AT	NULL
or	NULL
the	NULL
intact	NULL
IL-2	NULL
promoter	NULL
activity	NULL
,	NULL
while	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
stimulated	NULL
all	NULL
elements	NULL
.	NULL

Finally	NULL
,	NULL
using	NULL
activated	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
CD80	NULL
alone	NULL
,	NULL
we	NULL
also	NULL
observed	NULL
similar	NULL
CD28-mediated	NULL
proliferative	NULL
responses	NULL
that	NULL
also	NULL
proceeded	NULL
in	NULL
a	NULL
largely	NULL
IL-2-independent	NULL
manner	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
CD28	NULL
is	NULL
capable	NULL
of	NULL
T	NULL
cell	NULL
costimulation	NULL
independently	NULL
of	NULL
IL-2	NULL
and	NULL
NF-AT	NULL
in	NULL
a	NULL
CsA-resistant	NULL
manner	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
T	NULL
cell	NULL
purification	NULL
Purified	NULL
resting	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
human	NULL
donors	NULL
.	NULL

PBMC	NULL
were	NULL
isolated	NULL
by	NULL
density	NULL
gradient	NULL
centrifugation	NULL
at	NULL
800	NULL
X	NULL
g	NULL
for	NULL
30	NULL
min	NULL
(	NULL
Nycomed	NULL
1.077	NULL
g/ml	NULL
)	NULL
,	NULL
and	NULL
the	NULL
buoyant	NULL
layer	NULL
was	NULL
isolated	NULL
.	NULL

Following	NULL
two	NULL
washes	NULL
with	NULL
medium	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
further	NULL
purified	NULL
by	NULL
adhering	NULL
to	NULL
plastic	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
complete	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
+	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
antibiotics	NULL
)	NULL
.	NULL

Nonadherent	NULL
cells	NULL
containing	NULL
the	NULL
T	NULL
cell	NULL
population	NULL
were	NULL
recovered	NULL
and	NULL
incubated	NULL
with	NULL
mAbs	NULL
against	NULL
CD14	NULL
(	NULL
UCHM	NULL
!	NULL

1	NULL
)	NULL
,	NULL
HLA-DR	NULL
(	NULL
L243	NULL
)	NULL
,	NULL
and	NULL
CD19	NULL
(	NULL
BU12	NULL
)	NULL
.	NULL

Stained	NULL
cells	NULL
were	NULL
magnetically	NULL
removed	NULL
using	NULL
sheep	NULL
anti-mouse	NULL
IgG	NULL
magnetic	NULL
beads	NULL
(	NULL
Dynal	NULL
,	NULL
Oslo	NULL
,	NULL
Nor-way	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
cells	NULL
,	NULL
which	NULL
comprised	NULL
the	NULL
resting	NULL
T	NULL
cell	NULL
population	NULL
,	NULL
were	NULL
used	NULL
in	NULL
subsequent	NULL
experiments	NULL
.	NULL

For	NULL
experiments	NULL
using	NULL
T	NULL
cell	NULL
blasts	NULL
,	NULL
PBMCs	NULL
were	NULL
taken	NULL
following	NULL
density	NULL
gradient	NULL
centrifugation	NULL
and	NULL
washing	NULL
.	NULL

These	NULL
were	NULL
then	NULL
cultured	NULL
with	NULL
superantigen	NULL
SEA	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
complete	NULL
medium	NULL
.	NULL

After	NULL
4-6	NULL
days	NULL
,	NULL
blasts	NULL
were	NULL
washed	NULL
and	NULL
utilized	NULL
.	NULL

Transfectants	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
(	NULL
CHO	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
CD80	NULL
cDNA	NULL
expressed	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
CMV	NULL
promoter	NULL
,	NULL
generated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
glutamine-free	NULL
DMEM	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
plus	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
.	NULL

Before	NULL
use	NULL
,	NULL
cells	NULL
were	NULL
trypsinized	NULL
and	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
then	NULL
fixed	NULL
with	NULL
0.025	NULL
%	NULL
glutaraldehyde	NULL
in	NULL
PBS	NULL
for	NULL
2-3	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
extensively	NULL
with	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
counted	NULL
,	NULL
and	NULL
utilized	NULL
.	NULL

T	NULL
cell	NULL
proliferation	NULL
assays	NULL
Proliferation	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
in	NULL
96-well	NULL
plates	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
200	NULL
gl	NULL
per	NULL
well	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
antibiotics	NULL
.	NULL

T	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
cultured	NULL
either	NULL
alone	NULL
or	NULL
stimulated	NULL
as	NULL
specified	NULL
in	NULL
figure	NULL
legends	NULL
or	NULL
incubated	NULL
with	NULL
either	NULL
CHO	NULL
or	NULL
CHO-CD80	NULL
cells	NULL
at	NULL
a	NULL
ratio	NULL
of	NULL
3:1	NULL
T	NULL
cell	NULL
to	NULL
transfectants	NULL
.	NULL

Proliferation	NULL
was	NULL
measured	NULL
by	NULL
thymidine	NULL
incorporation	NULL
after	NULL
a	NULL
further	NULL
72	NULL
h.	NULL
Where	NULL
anti-CD28	NULL
Abs	NULL
were	NULL
used	NULL
,	NULL
the	NULL
Ab	NULL
9.3	NULL
was	NULL
added	NULL
at	NULL
1	NULL
pg/ml	NULL
and	NULL
cross-linked	NULL
using	NULL
sheep	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
5	NULL
ug/m	NULL
!	NULL
)	NULL

.	NULL

Assays	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
72	NULL
h	NULL
,	NULL
at	NULL
which	NULL
time	NULL
aliquots	NULL
were	NULL
removed	NULL
for	NULL
IL-2	NULL
analysis	NULL
(	NULL
DuoSet-ELISA	NULL
,	NULL
Gen-zyme	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
a	NULL
further	NULL
18	NULL
h	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
Ci	NULL
per	NULL
well	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
onto	NULL
96-well	NULL
filter	NULL
plates	NULL
using	NULL
a	NULL
Packard	NULL
(	NULL
Meriden	NULL
,	NULL
CT	NULL
)	NULL
96-well	NULL
harvester	NULL
,	NULL
and	NULL
[	NULL
*HJthymidine	NULL
uptake	NULL
was	NULL
determined	NULL
via	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

Blocking	NULL
Abs	NULL
were	NULL
added	NULL
at	NULL
the	NULL
start	NULL
of	NULL
culture	NULL
in	NULL
50-pl	NULL
volumes	NULL
to	NULL
the	NULL
final	NULL
concentrations	NULL
indicated	NULL
in	NULL
the	NULL
figures	NULL
.	NULL

Data	NULL
are	NULL
plotted	NULL
as	NULL
mean	NULL
values	NULL
of	NULL
triplicate	NULL
wells	NULL
.	NULL

SEs	NULL
were	NULL
always	NULL
less	NULL
than	NULL
10	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
value	NULL
.	NULL

IL-2-INDEPENDENT	NULL
T	NULL
CELL	NULL
PROLIFERATION	NULL
Carboxy	NULL
fluorescein	NULL
diacetate	NULL
succinimidyl	NULL
ester	NULL
labeling	NULL
To	NULL
determine	NULL
cell	NULL
division	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
resting	NULL
T	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
carboxy	NULL
fluorescein	NULL
diacetate	NULL
succinimidyl	NULL
ester	NULL
(	NULL
CFSE	NULL
)	NULL
(	NULL
Molecular	NULL
Probes	NULL
,	NULL
Leiden	NULL
,	NULL
NL	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
labeled	NULL
using	NULL
2.5	NULL
uM	NULL
CFSE	NULL
in	NULL
PBS	NULL
for	NULL
3	NULL
min	NULL
and	NULL
then	NULL
washed	NULL
twice	NULL
in	NULL
complete	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
stimulation	NULL
as	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
,	NULL
using	NULL
PMA	NULL
,	NULL
PMA	NULL
+CD80	NULL
,	NULL
and	NULL
PMA	NULL
+	NULL
ionomycin	NULL
,	NULL
and	NULL
fluorescence	NULL
was	NULL
monitored	NULL
by	NULL
FACS	NULL
at	NULL
various	NULL
times	NULL
after	NULL
stimulation	NULL
.	NULL

Luciferase	NULL
Assays	NULL
Plasmids	NULL
encoding	NULL
multimerized	NULL
NF-AT	NULL
,	NULL
NF-B	NULL
,	NULL
or	NULL
AP-1	NULL
or	NULL
the	NULL
complete	NULL
IL-2	NULL
promoter	NULL
were	NULL
used	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
(	NULL
5	NULL
%	NULL
10°	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
electroporation	NULL
at	NULL
320	NULL
V	NULL
,	NULL
960	NULL
LF	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
8	NULL
h	NULL
as	NULL
detailed	NULL
in	NULL
figure	NULL
legends	NULL
or	NULL
with	NULL
CHO	NULL
transfectants	NULL
at	NULL
a	NULL
1:3	NULL
ratio	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
performed	NULL
using	NULL
luciferase	NULL
assay	NULL
kit	NULL
(	NULL
Promega	NULL
,	NULL
Mad-ison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Two	NULL
freeze	NULL
and	NULL
thaw	NULL
cycles	NULL
in	NULL
liquid	NULL
nitrogen	NULL
aided	NULL
the	NULL
cytoplasmic	NULL
extraction	NULL
,	NULL
and	NULL
after	NULL
a	NULL
brief	NULL
centrifugation	NULL
20	NULL
pl	NULL
of	NULL
the	NULL
supernatant	NULL
was	NULL
used	NULL
with	NULL
100	NULL
pl	NULL
of	NULL
luciferase	NULL
assay	NULL
reagent	NULL
.	NULL

Luminescence	NULL
was	NULL
measured	NULL
immediately	NULL
for	NULL
10	NULL
s	NULL
with	NULL
the	NULL
TD-20/20	NULL
Lumi-nometer	NULL
or	NULL
using	NULL
a	NULL
Packard	NULL
Top	NULL
Count	NULL
.	NULL

FACS	NULL
analysis	NULL
FACS	NULL
analysis	NULL
was	NULL
undertaken	NULL
using	NULL
the	NULL
following	NULL
Abs	NULL
at	NULL
1	NULL
pg/ml	NULL
:	NULL
anti-CD2	NULL
(	NULL
OKT11	NULL
;	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
)	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
,	NULL
anti-CD25	NULL
(	NULL
HB8784	NULL
;	NULL
ATCC	NULL
)	NULL
,	NULL
anti-CD69	NULL
(	NULL
55.3.1	NULL
;	NULL
Serotec	NULL
,	NULL
Oxford	NULL
,	NULL
U.K.	NULL
)	NULL
,	NULL
and	NULL
anti-CD28	NULL
(	NULL
YTH913.12	NULL
;	NULL
Serotec	NULL
)	NULL
The	NULL
primary	NULL
Abs	NULL
were	NULL
added	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
the	NULL
secondary	NULL
anti-mouse	NULL
polyvalent	NULL
FITC	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
was	NULL
added	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Five	NULL
thousand	NULL
events	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
on	NULL
a	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
FACStar	NULL
``	NULL
``	NULL
``	NULL
using	NULL
a	NULL
488-nm	NULL
100-mW	NULL
laser	NULL
.	NULL

Results	NULL
PMA	NULL
plus	NULL
CD80	NULL
induces	NULL
proliferation	NULL
in	NULL
a	NULL
completely	NULL
CsA-resistant	NULL
fashion	NULL
Several	NULL
studies	NULL
have	NULL
used	NULL
PMA	NULL
in	NULL
synergy	NULL
with	NULL
Abs	NULL
to	NULL
CD28	NULL
to	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
CD28	NULL
as	NULL
a	NULL
costimulatory	NULL
receptor	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
7	NULL
,	NULL
27	NULL
)	NULL
.	NULL

However	NULL
,	NULL
few	NULL
of	NULL
these	NULL
studies	NULL
have	NULL
used	NULL
the	NULL
natural	NULL
ligands	NULL
of	NULL
CD28	NULL
,	NULL
and	NULL
confusion	NULL
has	NULL
arisen	NULL
over	NULL
the	NULL
sensitivity	NULL
of	NULL
CD28	NULL
costimulation	NULL
to	NULL
CsA	NULL
.	NULL

Since	NULL
stimulation	NULL
via	NULL
the	NULL
TCR	NULL
is	NULL
inherently	NULL
CsA	NULL
sensitive	NULL
,	NULL
we	NULL
utilized	NULL
the	NULL
ability	NULL
of	NULL
PMA	NULL
and	NULL
the	NULL
natural	NULL
ligand	NULL
CD80	NULL
to	NULL
costimulate	NULL
proliferative	NULL
responses	NULL
to	NULL
clarify	NULL
the	NULL
effect	NULL
of	NULL
CsA	NULL
on	NULL
the	NULL
CD28	NULL
pathway	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
purified	NULL
T	NULL
cells	NULL
proliferated	NULL
well	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
and	NULL
CHO-CD80	NULL
cells	NULL
together	NULL
,	NULL
although	NULL
not	NULL
to	NULL
either	NULL
stimulus	NULL
alone	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
type	NULL
stimulation	NULL
was	NULL
resistant	NULL
to	NULL
the	NULL
immunosup-pressive	NULL
drug	NULL
CsA	NULL
,	NULL
and	NULL
in	NULL
a	NULL
large	NULL
number	NULL
of	NULL
experiments	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
any	NULL
CsA	NULL
sensitivity	NULL
in	NULL
using	NULL
this	NULL
system	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
was	NULL
highly	NULL
sensitive	NULL
to	NULL
CsA	NULL
.	NULL

To	NULL
establish	NULL
that	NULL
both	NULL
forms	NULL
of	NULL
stimulation	NULL
resulted	NULL
in	NULL
expansion	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
similar	NULL
phenotypes	NULL
,	NULL
we	NULL
also	NULL
performed	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
activated	NULL
by	NULL
P	NULL
+I	NULL
and	NULL
PMA	NULL
+	NULL
CD80	NULL
.	NULL

These	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
confirmed	NULL
that	NULL
the	NULL
responding	NULL
T	NULL
cells	NULL
was	NULL
phenotypically	NULL
similar	NULL
in	NULL
each	NULL
case	NULL
and	NULL
displayed	NULL
typical	NULL
activation	NULL
markers	NULL
such	NULL
as	NULL
€D69	NULL
and	NULL
CD25	NULL
.	NULL

The	NULL
only	NULL
difference	NULL
observed	NULL
was	NULL
that	NULL
those	NULL
cells	NULL
that	NULL
received	NULL
CD80	NULL
stimulation	NULL
expressed	NULL
a	NULL
lower	NULL
level	NULL
of	NULL
CD28	NULL
,	NULL
which	NULL
occurs	NULL
as	NULL
a	NULL
result	NULL
of	NULL
ligand	NULL
engagement	NULL
and	NULL
is	NULL
due	NULL
to	NULL
receptor	NULL
internalization	NULL
(	NULL
18	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
however	NULL
,	NULL
these	NULL
experiments	NULL
clearly	NULL
demonstrated	NULL
that	NULL
costimulation	NULL
with	NULL
the	NULL
natural	NULL
ligand	NULL
CD80	NULL
resulted	NULL
in	NULL
proliferation	NULL
of	NULL
phenotypically	NULL
normal	NULL
cells	NULL
via	NULL
a	NULL
CsA-resistant	NULL
pathway	NULL
.	NULL

PMA	NULL
and	NULL
CD80	NULL
is	NULL
an	NULL
insufficient	NULL
signal	NULL
for	NULL
IL-2	NULL
production	NULL
Given	NULL
that	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
PMA	NULL
plus	NULL
CD80	NULL
was	NULL
completely	NULL
CsA	NULL
resistant	NULL
,	NULL
we	NULL
next	NULL
tested	NULL
whether	NULL
IL-2	NULL
production	NULL
was	NULL
similarly	NULL
unaffected	NULL
by	NULL
CsA	NULL
,	NULL
as	NULL
has	NULL
been	NULL
suggested	NULL
previously	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
I	NULL
Control	NULL
[	NULL
]	NULL
+Csa	NULL
50000	NULL
40000	NULL
=	NULL
30000	NULL
Q	NULL
20000	NULL
10000	NULL
O	NULL
&	NULL
T	NULL
fas	NULL
}	NULL
O	NULL
0	NULL
£	NULL
+	NULL
4	NULL
<	NULL
=	NULL
S	NULL
oa	NULL
A.	NULL
CD28	NULL
costimulation	NULL
is	NULL
CsA	NULL
resistant	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
of	NULL
control	NULL
CHO	NULL
cells	NULL
,	NULL
CD80	NULL
transfectants	NULL
,	NULL
anti-CD28	NULL
Abs	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
,	NULL
or	NULL
1	NULL
uM	NULL
ionomycin	NULL
.	NULL

Stimulations	NULL
were	NULL
conducted	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
hatched	NULL
bars	NULL
)	NULL
of	NULL
CsA	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
.	NULL

Proliferation	NULL
was	NULL
measured	NULL
at	NULL
72	NULL
h	NULL
by	NULL
the	NULL
incorporation	NULL
of	NULL
tritiated	NULL
thymidine	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

PMA	NULL
+	NULL
lono	NULL
FIGURE	NULL
1	NULL
.	NULL

(	NULL
27	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
measured	NULL
the	NULL
effect	NULL
of	NULL
CsA	NULL
on	NULL
IL-2	NULL
production	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
plus	NULL
CD80	NULL
stimulation	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
resting	NULL
human	NULL
T	NULL
cells	NULL
stimulated	NULL
in	NULL
this	NULL
manner	NULL
produced	NULL
very	NULL
limited	NULL
amounts	NULL
of	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
and	NULL
this	NULL
small	NULL
increase	NULL
was	NULL
sensitive	NULL
to	NULL
CsA	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
observed	NULL
substantial	NULL
production	NULL
of	NULL
IL-2	NULL
after	NULL
stimulation	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
1811	NULL
125	NULL
100	NULL
75	NULL
IL-2	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

50	NULL
25	NULL
O	NULL
O	NULL
I	NULL
fas	NULL
O	NULL
O	NULL
+	NULL
+	NULL
<	NULL
<	NULL
=	NULL
es	NULL
a	NULL
A	NULL
.	NULL

FIGURE	NULL
3	NULL
.	NULL

-	NULL
Purified	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
of	NULL
control	NULL
CHO	NULL
cells	NULL
,	NULL
CD80	NULL
transfectants	NULL
,	NULL
anti-CD28	NULL
Abs	NULL
(	NULL
1	NULL
pug/	NULL
ml	NULL
)	NULL
,	NULL
or	NULL
1	NULL
M	NULL
ionomycin	NULL
.	NULL

Stimulations	NULL
were	NULL
conducted	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
hatched	NULL
bars	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
of	NULL
CsA	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

IL-2	NULL
production	NULL
was	NULL
measured	NULL
at	NULL
72	NULL
h	NULL
by	NULL
ELISA	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

PMA	NULL
+	NULL
CD28	NULL
which	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
CsA	NULL
.	NULL

These	NULL
results	NULL
were	NULL
surprising	NULL
not	NULL
only	NULL
because	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
proliferate	NULL
to	NULL
PMA	NULL
and	NULL
CD80	NULL
despite	NULL
extremely	NULL
limited	NULL
amounts	NULL
of	NULL
IL-2	NULL
(	NULL
most	NULL
notably	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
)	NULL
but	NULL
also	NULL
because	NULL
previous	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
CD28	NULL
Abs	NULL
synergized	NULL
with	NULL
PMA	NULL
to	NULL
induce	NULL
IL-2	NULL
,	NULL
which	NULL
was	NULL
CsA	NULL
resistant	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
we	NULL
performed	NULL
Neg	NULL
.	NULL

CD2	NULL
CD25	NULL
CD28	NULL
CD69	NULL
g	NULL
g.	NULL
g	NULL
g.	NULL
3.	NULL
a8	NULL
34	NULL
3	NULL
34	NULL
s4	NULL
A	NULL
5s	NULL
34	NULL
3	NULL
34	NULL
94	NULL
80	NULL
o	NULL
3	NULL
o	NULL
o	NULL
3	NULL
o	NULL
}	NULL
10°	NULL
104	NULL
10°	NULL
104	NULL
10°	NULL
104	NULL
10°	NULL
104	NULL
10°	NULL
104	NULL
&	NULL
9	NULL
7	NULL
e	NULL
9	NULL
7	NULL
9	NULL
7	NULL
o	NULL
o	NULL
3	NULL
o	NULL
4	NULL
o	NULL
4	NULL
o	NULL
4	NULL
a	NULL
©	NULL
~	NULL
``	NULL
3	NULL
®	NULL
3	NULL
®	NULL
4	NULL
°	NULL
73	NULL
B	NULL
.	NULL

-	NULL
58	NULL
e	NULL
§	NULL
4	NULL
a	NULL
3	NULL
iQ	NULL
3	NULL
80	NULL
'	NULL
o	NULL
j	NULL
o	NULL
3	NULL
o	NULL
3	NULL
|	NULL
o	NULL
3	NULL
10°	NULL
104	NULL
10°	NULL
104	NULL
10°	NULL
104	NULL
10°	NULL
104	NULL
10°	NULL
10+	NULL
g	NULL
2	NULL
,	NULL
g	NULL
,	NULL
s	NULL
,	NULL
&	NULL
o	NULL
4	NULL
o	NULL
1	NULL
o	NULL
3	NULL
o	NULL
i	NULL
,	NULL
®	NULL
bake	NULL
®	NULL
7	NULL
e	NULL
ie	NULL
C.	NULL
38	NULL
a	NULL
a	NULL
3	NULL
84	NULL
R4	NULL
o	NULL
2	NULL
2	NULL
4	NULL
2	NULL
3	NULL
2	NULL
4	NULL
0	NULL
3	NULL
o	NULL
o	NULL
3	NULL
o	NULL
3	NULL
o	NULL
3	NULL
o	NULL
3	NULL
10°	NULL
104	NULL
10°	NULL
104	NULL
10°	NULL
104	NULL
10°	NULL
104	NULL
10°	NULL
10+	NULL
FL1-Height	NULL
FL1-Height	NULL
FL1-Height	NULL
FL1-Height	NULL
FL1-Height	NULL
FIGURE	NULL
2	NULL
.	NULL

PMA/CD80	NULL
or	NULL
P	NULL
+	NULL
I	NULL
give	NULL
rise	NULL
to	NULL
similar	NULL
activated	NULL
T	NULL
cell	NULL
phenotypes	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
alone	NULL
(	NULL
A	NULL
)	NULL
,	NULL
PMA	NULL
plus	NULL
CD80	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
was	NULL
performed	NULL
after	NULL
72	NULL
h	NULL
with	NULL
Abs	NULL
to	NULL
the	NULL
surface	NULL
markers	NULL
shown	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
for	NULL
FITC	NULL
fluorescence	NULL
at	NULL
520	NULL
nm	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
1812	NULL
similar	NULL
experiments	NULL
using	NULL
cross-linked	NULL
anti-CD28	NULL
Abs	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
we	NULL
also	NULL
observed	NULL
substantial	NULL
IL-2	NULL
production	NULL
,	NULL
which	NULL
was	NULL
not	NULL
evident	NULL
using	NULL
natural	NULL
ligand	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
level	NULL
of	NULL
cytokine	NULL
was	NULL
sensitive	NULL
to	NULL
CsA	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
derived	NULL
from	NULL
a	NULL
calcineurin-dependent	NULL
pathway	NULL
,	NULL
most	NULL
likely	NULL
due	NULL
to	NULL
calcium	NULL
signals	NULL
elicited	NULL
from	NULL
cross-linking	NULL
CD28	NULL
.	NULL

However	NULL
,	NULL
the	NULL
IL-2	NULL
production	NULL
stimulated	NULL
by	NULL
anti-CD28	NULL
,	NULL
while	NULL
mainly	NULL
sensitive	NULL
to	NULL
CsA	NULL
,	NULL
did	NULL
reveal	NULL
some	NULL
residual	NULL
CsA-resistant	NULL
IL-2	NULL
production	NULL
,	NULL
which	NULL
may	NULL
be	NULL
a	NULL
feature	NULL
of	NULL
anti-CD28	NULL
stimulation	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
results	NULL
clearly	NULL
demonstrated	NULL
an	NULL
obvious	NULL
disparity	NULL
between	NULL
the	NULL
ability	NULL
of	NULL
T	NULL
cell	NULL
to	NULL
proliferate	NULL
to	NULL
PMA	NULL
and	NULL
CD80	NULL
stimulation	NULL
and	NULL
their	NULL
ability	NULL
to	NULL
produce	NULL
IL-2	NULL
.	NULL

This	NULL
suggested	NULL
several	NULL
possibilities	NULL
;	NULL
either	NULL
small	NULL
amounts	NULL
of	NULL
IL-2	NULL
could	NULL
sustain	NULL
high	NULL
levels	NULL
of	NULL
proliferation	NULL
,	NULL
the	NULL
T	NULL
cells	NULL
consumed	NULL
IL-2	NULL
more	NULL
rapidly	NULL
when	NULL
stimulated	NULL
by	NULL
PMA	NULL
and	NULL
CD80	NULL
,	NULL
or	NULL
that	NULL
T	NULL
cell	NULL
proliferation	NULL
may	NULL
not	NULL
be	NULL
IL-2	NULL
dependent	NULL
in	NULL
this	NULL
system	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
data	NULL
highlighted	NULL
substantial	NULL
differences	NULL
between	NULL
the	NULL
results	NULL
obtained	NULL
using	NULL
anti-CD28	NULL
Abs	NULL
and	NULL
natural	NULL
ligands	NULL
.	NULL

PMA	NULL
and	NULL
CD80	NULL
stimulate	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
transactivation	NULL
but	NULL
not	NULL
NF-AT	NULL
or	NULL
the	NULL
intact	NULL
IL-2	NULL
promoter	NULL
To	NULL
further	NULL
understand	NULL
the	NULL
differences	NULL
in	NULL
signaling	NULL
between	NULL
PMA	NULL
and	NULL
CD80	NULL
compared	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
and	NULL
their	NULL
differential	NULL
effects	NULL
on	NULL
IL-2	NULL
production	NULL
,	NULL
we	NULL
next	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
stimuli	NULL
on	NULL
the	NULL
transcription	NULL
factors	NULL
NFB	NULL
,	NULL
AP-1	NULL
,	NULL
NF-AT	NULL
and	NULL
on	NULL
the	NULL
intact	NULL
IL-2	NULL
promoter	NULL
.	NULL

To	NULL
establish	NULL
the	NULL
effect	NULL
of	NULL
CD80	NULL
on	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
its	NULL
components	NULL
,	NULL
we	NULL
used	NULL
luciferase	NULL
reporters	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
PMA	NULL
alone	NULL
was	NULL
unable	NULL
to	NULL
induce	NULL
substantial	NULL
NF-KB	NULL
activity	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
ionomycin	NULL
,	NULL
and	NULL
as	NULL
expected	NULL
this	NULL
activation	NULL
was	NULL
fully	NULL
blocked	NULL
by	NULL
CsA	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CD80	NULL
was	NULL
also	NULL
able	NULL
to	NULL
partially	NULL
activate	NULL
NF-KB	NULL
,	NULL
increasing	NULL
the	NULL
response	NULL
~2-fold	NULL
over	NULL
PMA	NULL
alone	NULL
,	NULL
but	NULL
,	NULL
notably	NULL
,	NULL
this	NULL
enhancement	NULL
was	NULL
resistant	NULL
to	NULL
CsA	NULL
,	NULL
suggesting	NULL
that	NULL
pathways	NULL
leading	NULL
from	NULL
CD28	NULL
to	NULL
NFB	NULL
stimulation	NULL
could	NULL
be	NULL
partially	NULL
responsible	NULL
for	NULL
the	NULL
CsA-resistant	NULL
costimulatory	NULL
effect	NULL
of	NULL
CD28	NULL
.	NULL

Similar	NULL
experiments	NULL
were	NULL
also	NULL
performed	NULL
using	NULL
AP-1	NULL
reporter	NULL
constructs	NULL
.	NULL

In	NULL
examining	NULL
the	NULL
transactivation	NULL
of	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
PMA	NULL
was	NULL
found	NULL
to	NULL
strongly	NULL
induce	NULL
AP-1	NULL
luciferase	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
enhanced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
ionomycin	NULL
and	NULL
blocked	NULL
by	NULL
CsA	NULL
.	NULL

Significantly	NULL
,	NULL
CD80	NULL
stimulation	NULL
also	NULL
enhanced	NULL
the	NULL
PMA-driven	NULL
response	NULL
,	NULL
and	NULL
like	NULL
NFB	NULL
this	NULL
was	NULL
completely	NULL
resistant	NULL
to	NULL
CsA	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
NFB	NULL
and	NULL
AP-1	NULL
responses	NULL
were	NULL
stimulated	NULL
by	NULL
CD28	NULL
in	NULL
a	NULL
CsA-resistant	NULL
manner	NULL
.	NULL

We	NULL
also	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
PMA	NULL
and	NULL
CD80	NULL
stimulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
both	NULL
NFE-AT	NULL
and	NULL
the	NULL
whole	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
C	NULL
and	NULL
D	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
NF-AT	NULL
transcription	NULL
factor	NULL
is	NULL
known	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
calcium	NULL
signaling	NULL
,	NULL
and	NULL
specifically	NULL
calcineurin	NULL
,	NULL
for	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
an	NULL
event	NULL
that	NULL
is	NULL
blocked	NULL
by	NULL
CsA	NULL
(	NULL
9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
partially	NULL
calcineurin-indepen-dent	NULL
mechanism	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
be	NULL
initiated	NULL
by	NULL
CD28	NULL
Abs	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Using	NULL
luciferase	NULL
assays	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
strong	NULL
NF-AT	NULL
response	NULL
to	NULL
stimulation	NULL
by	NULL
PMA	NULL
and	NULL
ionomycin	NULL
that	NULL
,	NULL
as	NULL
predicted	NULL
,	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
CsA	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
our	NULL
results	NULL
for	NULL
NFB	NULL
and	NULL
AP-1	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
significantly	NULL
activate	NULL
the	NULL
NF-AT	NULL
reporter	NULL
construct	NULL
with	NULL
the	NULL
PMA	NULL
and	NULL
CD80	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
using	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
the	NULL
whole	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
,	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
to	NULL
those	NULL
with	NULL
NF-AT	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
however	NULL
,	NULL
CD80	NULL
was	NULL
able	NULL
to	NULL
slightly	NULL
enhance	NULL
IL-2	NULL
activation	NULL
induced	NULL
by	NULL
PMA	NULL
,	NULL
although	NULL
this	NULL
effect	NULL
was	NULL
blocked	NULL
by	NULL
CsA	NULL
,	NULL
suggesting	NULL
it	NULL
could	NULL
not	NULL
account	NULL
for	NULL
the	NULL
CsA-resistant	NULL
CD28	NULL
effect	NULL
on	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

However	NULL
,	NULL
we	NULL
did	NULL
observe	NULL
that	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
P	NULL
+I	NULL
,	NULL
CD80	NULL
stimulation	NULL
was	NULL
able	NULL
to	NULL
further	NULL
stimulate	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
CD28	NULL
could	NULL
only	NULL
significantly	NULL
aug	NULL
IL-2-INDEPENDENT	NULL
T	NULL
CELL	NULL
PROLIFERATION	NULL
Luciferase	NULL
units	NULL
Luciferase	NULL
units	NULL
P+CD80+CsA	NULL
O	NULL
Luciferase	NULL
units	NULL
Luciferase	NULL
units	NULL
P+CD80+CsA	NULL
Luciferase	NULL
units	NULL
Luciferase	NULL
units	NULL
PMA-CD28	NULL
PMA-CD28®	NULL
PMA-CO28	NULL
PMA-CD28	NULL
9	NULL
®	NULL
a	NULL
O	NULL
+	NULL
<	NULL
2	NULL
&	NULL
PMA+	NULL
CD80	NULL
FIGURE	NULL
4	NULL
.	NULL

IL-2	NULL
promoter	NULL
activity	NULL
is	NULL
poorly	NULL
stimulated	NULL
by	NULL
PMA/CD80	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
Jurkat	NULL
cells	NULL
using	NULL
reporters	NULL
linked	NULL
to	NULL
NF-KB	NULL
(	NULL
4	NULL
)	NULL
,	NULL
AP-1	NULL
(	NULL
B	NULL
)	NULL
,	NULL
NF-AT	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
the	NULL
intact	NULL
IL-2	NULL
promoter	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Experiments	NULL
comparing	NULL
CD80	NULL
and	NULL
anti-CD28	NULL
are	NULL
shown	NULL
for	NULL
NF-AT	NULL
(	NULL
E	NULL
)	NULL
and	NULL
IL-2	NULL
(	NULL
F	NULL
)	NULL
.	NULL

Stimulations	NULL
(	NULL
8	NULL
h	NULL
)	NULL
were	NULL
performed	NULL
24	NULL
h	NULL
following	NULL
transfection	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
detected	NULL
using	NULL
a	NULL
luminometer	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

ment	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
the	NULL
context	NULL
of	NULL
calcium-dependent	NULL
signals	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
experiments	NULL
,	NULL
we	NULL
also	NULL
directly	NULL
compared	NULL
the	NULL
abilities	NULL
of	NULL
CD80	NULL
and	NULL
anti-CD28	NULL
mAb	NULL
for	NULL
their	NULL
abilities	NULL
to	NULL
stimulate	NULL
NF-AT	NULL
(	NULL
E	NULL
)	NULL
and	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
F	NULL
)	NULL
constructs	NULL
.	NULL

These	NULL
results	NULL
showed	NULL
similar	NULL
findings	NULL
for	NULL
both	NULL
constructs	NULL
in	NULL
that	NULL
both	NULL
PMA/	NULL
CD80	NULL
and	NULL
PMA	NULL
plus	NULL
CD28	NULL
Abs	NULL
(	NULL
not	NULL
cross-linked	NULL
)	NULL
were	NULL
poor	NULL
stim-ulators	NULL
of	NULL
the	NULL
constructs	NULL
.	NULL

However	NULL
,	NULL
cross-linking	NULL
of	NULL
the	NULL
anti-CD28	NULL
Ab	NULL
using	NULL
a	NULL
sheep	NULL
anti-mouse	NULL
Ig	NULL
consistently	NULL
gave	NULL
a	NULL
2-	NULL
to	NULL
3-fold	NULL
stimulation	NULL
of	NULL
both	NULL
NF-AT	NULL
and	NULL
IL-2	NULL
,	NULL
suggesting	NULL
that	NULL
cross-linking	NULL
CD28	NULL
Abs	NULL
provides	NULL
different	NULL
signals	NULL
to	NULL
the	NULL
natural	NULL
ligand	NULL
.	NULL

This	NULL
observation	NULL
was	NULL
consistent	NULL
with	NULL
our	NULL
observations	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
suggesting	NULL
that	NULL
cross-linked	NULL
anti-CD28	NULL
Ab	NULL
and	NULL
CD80	NULL
ligand	NULL
had	NULL
different	NULL
effects	NULL
on	NULL
IL-2	NULL
transcription	NULL
.	NULL

However	NULL
,	NULL
it	NULL
was	NULL
notable	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
luciferase	NULL
activity	NULL
seen	NULL
with	NULL
cross-linked	NULL
anti-CD28	NULL
were	NULL
at	NULL
least	NULL
10-fold	NULL
lower	NULL
than	NULL
those	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
in	NULL
the	NULL
same	NULL
assay	NULL
.	NULL

Overall	NULL
,	NULL
however	NULL
these	NULL
results	NULL
indicated	NULL
that	NULL
both	NULL
NFB	NULL
and	NULL
AP-1	NULL
responses	NULL
were	NULL
stimulated	NULL
by	NULL
CD28	NULL
ligation	NULL
and	NULL
that	NULL
the	NULL
pathways	NULL
leading	NULL
to	NULL
activation	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
were	NULL
CsA	NULL
resistant	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PMA	NULL
and	NULL
CD80	NULL
did	NULL
not	NULL
effectively	NULL
stimulate	NULL
NF-AT	NULL
or	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
calcium	NULL
flux	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
data	NULL
from	NULL
normal	NULL
T	NULL
cell	NULL
stimulations	NULL
,	NULL
indicating	NULL
that	NULL
IL-2	NULL
transcription	NULL
was	NULL
poorly	NULL
stimulated	NULL
in	NULL
response	NULL
to	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
--	NULL
Q	NULL
--	NULL
_	NULL
CD3+CD80	NULL
A	NULL
__	NULL
PMA+CD80	NULL
100000	NULL
--	NULL
O	NULL
--	NULL
_	NULL
PMA+Iono	NULL
75000	NULL
ps	NULL
A	NULL
.	NULL

*	NULL
50000	NULL
25000	NULL
0	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
3	NULL
c	NULL
<	NULL
ou	NULL
o	NULL
8	NULL
o	NULL
(	NULL
a	NULL
)	NULL
ha	NULL
a	NULL
6	NULL
®	NULL
T	NULL
2	NULL
_	NULL
anti-lL-2	NULL
(	NULL
ug/ml	NULL
)	NULL
--	NULL
LQ	NULL
--	NULL
CD3+CD80	NULL
B	NULL
.	NULL

--	NULL
i	NULL
&	NULL
--	NULL
__	NULL
PMA+CD80	NULL
125000	NULL
--	NULL
O	NULL
--	NULL
__	NULL
PMA+Iono	NULL
100000	NULL
a	NULL
75000	NULL
A	NULL
.	NULL

50000	NULL
25000	NULL
0	NULL
T	NULL
T	NULL
T	NULL
T	NULL
he	NULL
]	NULL
co	NULL
t	NULL
ou	NULL
fa	NULL
:	NULL
2	NULL
o	NULL
o	NULL
*~	NULL
©	NULL
o	NULL
®	NULL
<	NULL
D	NULL
anti-IL-2R	NULL
(	NULL
ug/ml	NULL
)	NULL
FIGURE	NULL
5	NULL
.	NULL

PMA/CD80	NULL
costimulation	NULL
does	NULL
not	NULL
depend	NULL
on	NULL
IL-2	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
blocking	NULL
Abs	NULL
to	NULL
IL-2	NULL
(	NULL
4	NULL
)	NULL
and	NULL
IL-2R	NULL
(	NULL
B	NULL
)	NULL
were	NULL
tested	NULL
on	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
PI	NULL
(	NULL
circles	NULL
)	NULL
,	NULL
PMA	NULL
and	NULL
CD80	NULL
(	NULL
triangles	NULL
)	NULL
,	NULL
or	NULL
CD3	NULL
and	NULL
CD80	NULL
(	NULL
squares	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
on	NULL
cell	NULL
proliferation	NULL
were	NULL
measured	NULL
by	NULL
tritiated	NULL
thymidine	NULL
incorporation	NULL
at	NULL
72	NULL
h.	NULL
PMA	NULL
and	NULL
CD80	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
assays	NULL
further	NULL
revealed	NULL
differences	NULL
in	NULL
the	NULL
ability	NULL
of	NULL
anti-CD28	NULL
to	NULL
stimulate	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
depending	NULL
on	NULL
whether	NULL
or	NULL
not	NULL
the	NULL
Ab	NULL
was	NULL
cross-linked	NULL
.	NULL

Anti-IL-2	NULL
and	NULL
anti-IL-2R	NULL
Abs	NULL
do	NULL
not	NULL
inhibit	NULL
PMA	NULL
+	NULL
CD80	NULL
proliferation	NULL
Taking	NULL
the	NULL
above	NULL
results	NULL
together	NULL
,	NULL
it	NULL
did	NULL
not	NULL
appear	NULL
that	NULL
IL-2	NULL
was	NULL
likely	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
T	NULL
cell	NULL
proliferation	NULL
to	NULL
PMA	NULL
and	NULL
CD80	NULL
stimulation	NULL
.	NULL

Nonetheless	NULL
,	NULL
since	NULL
it	NULL
was	NULL
still	NULL
formally	NULL
possible	NULL
that	NULL
PMA-	NULL
and	NULL
CD8O-stimulated	NULL
T	NULL
cells	NULL
produced	NULL
small	NULL
amounts	NULL
of	NULL
IL-2	NULL
sufficient	NULL
to	NULL
drive	NULL
proliferation	NULL
,	NULL
we	NULL
examined	NULL
this	NULL
possibility	NULL
using	NULL
blocking	NULL
Abs	NULL
to	NULL
IL-2	NULL
and	NULL
the	NULL
IL-2R	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
proliferation	NULL
of	NULL
the	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
CD80	NULL
1813	NULL
25000	NULL
+CHO	NULL
20000	NULL
W	NULL
cHo-coso	NULL
15000	NULL
CPM	NULL
10000	NULL
5000	NULL
Untreated	NULL
Anti-IL-2	NULL
(	NULL
ug/ml	NULL
)	NULL
FIGURE	NULL
6	NULL
.	NULL

CD80	NULL
stimulation	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
is	NULL
substantially	NULL
IL-2	NULL
independent	NULL
.	NULL

SEA-activated	NULL
T	NULL
cell	NULL
blasts	NULL
were	NULL
stimulated	NULL
for	NULL
5	NULL
days	NULL
and	NULL
then	NULL
rechallenged	NULL
with	NULL
either	NULL
CHO	NULL
cells	NULL
(	NULL
hatched	NULL
bars	NULL
)	NULL
or	NULL
CHO-CD80	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
anti-IL-2	NULL
was	NULL
tested	NULL
at	NULL
the	NULL
doses	NULL
shown	NULL
,	NULL
and	NULL
proliferation	NULL
was	NULL
measured	NULL
by	NULL
thymidine	NULL
incorporation	NULL
36	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
similar	NULL
experiments	NULL
.	NULL

was	NULL
not	NULL
inhibited	NULL
by	NULL
blocking	NULL
Abs	NULL
to	NULL
either	NULL
IL-2	NULL
or	NULL
the	NULL
IL-2R	NULL
,	NULL
demonstrating	NULL
that	NULL
IL-2	NULL
was	NULL
not	NULL
responsible	NULL
for	NULL
the	NULL
proliferative	NULL
response	NULL
to	NULL
PMA	NULL
and	NULL
CD80	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
if	NULL
anything	NULL
,	NULL
these	NULL
Abs	NULL
caused	NULL
slight	NULL
enhancement	NULL
of	NULL
responses	NULL
.	NULL

This	NULL
lack	NULL
of	NULL
inhibition	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
Abs	NULL
to	NULL
block	NULL
since	NULL
substantial	NULL
inhibition	NULL
was	NULL
observed	NULL
in	NULL
T	NULL
cell	NULL
responses	NULL
stimulated	NULL
by	NULL
either	NULL
anti-CD3	NULL
plus	NULL
CD80	NULL
or	NULL
with	NULL
P	NULL
+	NULL
I	NULL
.	NULL

However	NULL
,	NULL
these	NULL
Abs	NULL
only	NULL
partially	NULL
inhibited	NULL
proliferation	NULL
to	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
indicating	NULL
that	NULL
,	NULL
like	NULL
PMA	NULL
+	NULL
CD80	NULL
,	NULL
this	NULL
response	NULL
was	NULL
also	NULL
only	NULL
partially	NULL
IL-2	NULL
depen-dent	NULL
.	NULL

Nonetheless	NULL
,	NULL
it	NULL
was	NULL
clear	NULL
from	NULL
these	NULL
experiments	NULL
that	NULL
IL-2	NULL
was	NULL
not	NULL
required	NULL
to	NULL
sustain	NULL
proliferation	NULL
to	NULL
PMA	NULL
and	NULL
CD80	NULL
.	NULL

Activated	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
stimulated	NULL
by	NULL
CD80	NULL
in	NULL
a	NULL
largely	NULL
IL-2-independent	NULL
manner	NULL
The	NULL
above	NULL
situation	NULL
,	NULL
where	NULL
T	NULL
cells	NULL
proliferated	NULL
well	NULL
despite	NULL
their	NULL
inability	NULL
to	NULL
generate	NULL
significant	NULL
quantities	NULL
of	NULL
IL-2	NULL
or	NULL
activate	NULL
components	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
was	NULL
reminiscent	NULL
of	NULL
our	NULL
previous	NULL
studies	NULL
using	NULL
activated	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
capable	NULL
of	NULL
responding	NULL
to	NULL
CD80	NULL
ligation	NULL
alone	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Given	NULL
that	NULL
PMA	NULL
stimulation	NULL
is	NULL
not	NULL
a	NULL
physiologically	NULL
relevant	NULL
stimulus	NULL
,	NULL
we	NULL
wondered	NULL
whether	NULL
CD80	NULL
stimulation	NULL
of	NULL
T	NULL
cell	NULL
blasts	NULL
might	NULL
represent	NULL
a	NULL
similar	NULL
situation	NULL
where	NULL
IL-2	NULL
was	NULL
not	NULL
required	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
CD80	NULL
stimulation	NULL
on	NULL
SEA-activated	NULL
T	NULL
cell	NULL
blasts	NULL
.	NULL

Accordingly	NULL
,	NULL
5-day-old	NULL
blasts	NULL
were	NULL
washed	NULL
and	NULL
then	NULL
recultured	NULL
with	NULL
either	NULL
CD80	NULL
or	NULL
CHO	NULL
control	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
anti	NULL
IL-2	NULL
Abs	NULL
were	NULL
tested	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
the	NULL
CD80-stimulated	NULL
cells	NULL
continued	NULL
to	NULL
proliferate	NULL
whereas	NULL
the	NULL
control	NULL
cells	NULL
did	NULL
not	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
blocking	NULL
anti-IL-2	NULL
Abs	NULL
revealed	NULL
that	NULL
this	NULL
inhibited	NULL
only	NULL
~20	NULL
%	NULL
of	NULL
the	NULL
response	NULL
,	NULL
indicating	NULL
that	NULL
IL-2	NULL
was	NULL
also	NULL
not	NULL
essential	NULL
for	NULL
T	NULL
cell	NULL
proliferation	NULL
under	NULL
these	NULL
circumstances	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
experiments	NULL
confirmed	NULL
the	NULL
possibility	NULL
that	NULL
IL-2-independent	NULL
T	NULL
cell	NULL
proliferation	NULL
may	NULL
also	NULL
occur	NULL
under	NULL
more	NULL
physiological	NULL
circumstances	NULL
.	NULL

PMA	NULL
+	NULL
CD80-stimulated	NULL
cells	NULL
undergo	NULL
cell	NULL
division	NULL
Finally	NULL
,	NULL
given	NULL
that	NULL
tritiated	NULL
thymidine	NULL
incorporation	NULL
represents	NULL
DNA	NULL
labeling	NULL
in	NULL
S	NULL
phase	NULL
,	NULL
but	NULL
not	NULL
necessarily	NULL
actual	NULL
cell	NULL
division	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
PMA-	NULL
and	NULL
CD80-stimulated	NULL
cells	NULL
divided	NULL
similarly	NULL
to	NULL
cells	NULL
from	NULL
P	NULL
+	NULL
I-stimulated	NULL
cultures	NULL
.	NULL

This	NULL
was	NULL
done	NULL
using	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
1814	NULL
J	NULL
»	NULL
100	NULL
60	NULL
Counts	NULL
40	NULL
0	NULL
_	NULL
10	NULL
FL1-Height	NULL
B	NULL
3-7	NULL
PMA+CD8O	NULL
o	NULL
{	NULL
Q	NULL
_	NULL
Counts	NULL
1	NULL
2	NULL
3	NULL
4	NULL
10	NULL
10	NULL
10	NULL
FL1-Height	NULL
O	NULL
150	NULL
PMA	NULL
+lono	NULL
120	NULL
ia	NULL
Counts	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
10	NULL
10	NULL
10	NULL
10	NULL
10	NULL
FL1-Height	NULL
FIGURE	NULL
7	NULL
.	NULL

PMA	NULL
+	NULL
CD80	NULL
causes	NULL
T	NULL
cell	NULL
division	NULL
.	NULL

Resting	NULL
T	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
2.5	NULL
M	NULL
CFSE	NULL
and	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
4	NULL
)	NULL
,	NULL
PMA	NULL
+	NULL
CD80	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
+	NULL
ionomycin	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
for	NULL
fluorescence	NULL
by	NULL
FACS	NULL
on	NULL
the	NULL
day	NULL
of	NULL
labeling	NULL
(	NULL
d.1	NULL
)	NULL
or	NULL
on	NULL
days	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
as	NULL
shown	NULL
.	NULL

both	NULL
cell	NULL
counting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
assessment	NULL
of	NULL
cell	NULL
division	NULL
using	NULL
CFSE	NULL
labeling	NULL
(	NULL
30	NULL
)	NULL
.	NULL

By	NULL
labeling	NULL
T	NULL
cells	NULL
before	NULL
cell	NULL
division	NULL
with	NULL
CFSE	NULL
,	NULL
cell	NULL
division	NULL
can	NULL
then	NULL
be	NULL
monitored	NULL
by	NULL
the	NULL
decrease	NULL
in	NULL
dye	NULL
content	NULL
of	NULL
the	NULL
cells	NULL
as	NULL
the	NULL
dye	NULL
is	NULL
divided	NULL
between	NULL
daughter	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
indicated	NULL
that	NULL
,	NULL
over	NULL
a	NULL
7-day	NULL
period	NULL
,	NULL
the	NULL
CFSE	NULL
content	NULL
of	NULL
the	NULL
cells	NULL
decreased	NULL
over	NULL
10-fold	NULL
in	NULL
the	NULL
PMA	NULL
+	NULL
CD80	NULL
(	NULL
Fig	NULL
.	NULL

78	NULL
)	NULL
and	NULL
the	NULL
P	NULL
+	NULL
I	NULL
cultures	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
alone	NULL
did	NULL
not	NULL
show	NULL
any	NULL
decrease	NULL
in	NULL
cell	NULL
staining	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
viable	NULL
cell	NULL
numbers	NULL
increased	NULL
in	NULL
the	NULL
PMA	NULL
+	NULL
CD80	NULL
and	NULL
P	NULL
+	NULL
I	NULL
cultures	NULL
by	NULL
~6-fold	NULL
over	NULL
the	NULL
same	NULL
period	NULL
.	NULL

Taken	NULL
IL-2-INDEPENDENT	NULL
T	NULL
CELL	NULL
PROLIFERATION	NULL
W	NULL
Contro	NULL
!	NULL

20000	NULL
15000	NULL
=	NULL
B	NULL
&	NULL
10000	NULL
5000	NULL
0	NULL
o	NULL
0	NULL
g	NULL
-	NULL
g	NULL
9	NULL
IC	NULL
fast	NULL
5	NULL
-3	NULL
O	NULL
0	NULL
+	NULL
p	NULL
4	NULL
S	NULL
s	NULL
S	NULL
a	NULL
[	NULL
anl	NULL
a	NULL
.	NULL

FIGURE	NULL
8	NULL
.	NULL

PMA	NULL
and	NULL
CD80	NULL
stimulates	NULL
production	NULL
of	NULL
a	NULL
CsA-resistant	NULL
proliferative	NULL
factor	NULL
.	NULL

Resting	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
+	NULL
CHO	NULL
,	NULL
PMA	NULL
+	NULL
CD80	NULL
,	NULL
or	NULL
PI	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
CsA	NULL
(	NULL
hatched	NULL
bars	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
removed	NULL
and	NULL
applied	NULL
to	NULL
3-day-old	NULL
T	NULL
cell	NULL
blasts	NULL
with	NULL
IL-2	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Proliferation	NULL
was	NULL
measured	NULL
36	NULL
h	NULL
after	NULL
the	NULL
transfer	NULL
of	NULL
supernatant	NULL
by	NULL
tritiated	NULL
thymidine	NULL
incorporation	NULL
.	NULL

together	NULL
,	NULL
these	NULL
data	NULL
provided	NULL
unequivocal	NULL
evidence	NULL
that	NULL
the	NULL
T	NULL
cells	NULL
were	NULL
undergoing	NULL
cell	NULL
division	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
+	NULL
CD80	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
was	NULL
IL-2	NULL
independent	NULL
.	NULL

PMA	NULL
+	NULL
CD80-dependent	NULL
T	NULL
cell	NULL
proliferation	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
soluble	NULL
factor	NULL
Whereas	NULL
we	NULL
had	NULL
established	NULL
that	NULL
IL-2	NULL
was	NULL
not	NULL
responsible	NULL
for	NULL
T	NULL
cell	NULL
responses	NULL
to	NULL
PMA	NULL
and	NULL
CD80	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
establish	NULL
whether	NULL
proliferation	NULL
was	NULL
dependent	NULL
on	NULL
a	NULL
soluble	NULL
factor	NULL
or	NULL
whether	NULL
CD28	NULL
signals	NULL
were	NULL
driving	NULL
proliferation	NULL
directly	NULL
.	NULL

To	NULL
test	NULL
this	NULL
,	NULL
we	NULL
transferred	NULL
supernatants	NULL
from	NULL
cultures	NULL
stimulated	NULL
with	NULL
various	NULL
treatments	NULL
onto	NULL
previously	NULL
activated	NULL
day	NULL
5	NULL
T	NULL
cell	NULL
blasts	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
this	NULL
revealed	NULL
that	NULL
treatment	NULL
with	NULL
PMA	NULL
and	NULL
CD80	NULL
resulted	NULL
in	NULL
the	NULL
secretion	NULL
of	NULL
a	NULL
soluble	NULL
factor	NULL
that	NULL
could	NULL
cause	NULL
proliferation	NULL
when	NULL
transferred	NULL
to	NULL
T	NULL
cell	NULL
blasts	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
supernatant	NULL
from	NULL
PMA	NULL
+	NULL
ionomycin	NULL
stimulation	NULL
could	NULL
also	NULL
transfer	NULL
a	NULL
proliferative	NULL
stimulus	NULL
;	NULL
however	NULL
,	NULL
in	NULL
keeping	NULL
with	NULL
our	NULL
other	NULL
observations	NULL
,	NULL
CsA	NULL
strongly	NULL
inhibited	NULL
PMA	NULL
+	NULL
ionomycin-	NULL
but	NULL
not	NULL
PMA	NULL
+	NULL
CD80-derived	NULL
supernatants	NULL
.	NULL

Interestingly	NULL
,	NULL
these	NULL
effects	NULL
were	NULL
of	NULL
similar	NULL
potency	NULL
as	NULL
the	NULL
addition	NULL
of	NULL
IL-2	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
experiment	NULL
indicated	NULL
that	NULL
cytokines	NULL
were	NULL
involved	NULL
in	NULL
both	NULL
forms	NULL
of	NULL
proliferation	NULL
although	NULL
it	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
different	NULL
cytokines	NULL
may	NULL
be	NULL
in-volved	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
stimulation	NULL
conditions	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
report	NULL
a	NULL
CD28-dependent	NULL
form	NULL
of	NULL
T	NULL
cell	NULL
stimulation	NULL
that	NULL
is	NULL
resistant	NULL
to	NULL
CsA	NULL
and	NULL
independent	NULL
of	NULL
IL-2	NULL
.	NULL

Using	NULL
the	NULL
natural	NULL
ligand	NULL
CD80	NULL
transfected	NULL
into	NULL
CHO	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
CD80	NULL
synergizes	NULL
with	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
to	NULL
induce	NULL
proliferation	NULL
of	NULL
purified	NULL
resting	NULL
T	NULL
cells	NULL
despite	NULL
being	NULL
severely	NULL
compromised	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
produce	NULL
IL-2	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
this	NULL
form	NULL
of	NULL
stimulation	NULL
was	NULL
completely	NULL
CsA	NULL
resistant	NULL
,	NULL
suggesting	NULL
it	NULL
did	NULL
not	NULL
depend	NULL
on	NULL
the	NULL
phosphatase	NULL
activity	NULL
of	NULL
calcineurin	NULL
,	NULL
an	NULL
enzyme	NULL
known	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
nuclear	NULL
entry	NULL
of	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
the	NULL
transcription	NULL
factor	NULL
NF-AT	NULL
and	NULL
control	NULL
of	NULL
IL-2	NULL
gene	NULL
transcription	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

This	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
CsA	NULL
on	NULL
CD28	NULL
costimulation	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
reported	NULL
by	NULL
others	NULL
(	NULL
7	NULL
,	NULL
27	NULL
)	NULL
;	NULL
however	NULL
,	NULL
there	NULL
are	NULL
several	NULL
differences	NULL
between	NULL
our	NULL
observations	NULL
and	NULL
those	NULL
previously	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
any	NULL
sensitivity	NULL
of	NULL
CD8O-stimulated	NULL
CD28	NULL
to	NULL
CsA	NULL
;	NULL
this	NULL
contrasts	NULL
to	NULL
the	NULL
observations	NULL
of	NULL
Linsley	NULL
(	NULL
7	NULL
)	NULL
,	NULL
who	NULL
suggested	NULL
that	NULL
a	NULL
CsA-sensitive	NULL
pathway	NULL
may	NULL
also	NULL
derive	NULL
from	NULL
CD28	NULL
.	NULL

We	NULL
believe	NULL
these	NULL
differences	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
use	NULL
of	NULL
Abs	NULL
vs	NULL
natural	NULL
ligands	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
own	NULL
data	NULL
using	NULL
cross-linked	NULL
anti-CD28	NULL
Abs	NULL
indicate	NULL
that	NULL
this	NULL
type	NULL
of	NULL
stimulation	NULL
does	NULL
lead	NULL
to	NULL
an	NULL
apparent	NULL
CsA	NULL
sensitivity	NULL
in	NULL
the	NULL
CD28	NULL
pathway	NULL
,	NULL
which	NULL
while	NULL
inhibiting	NULL
IL-2	NULL
production	NULL
does	NULL
not	NULL
affect	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

Our	NULL
findings	NULL
also	NULL
contrast	NULL
somewhat	NULL
with	NULL
the	NULL
findings	NULL
of	NULL
June	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
,	NULL
who	NULL
observed	NULL
that	NULL
CD28-costimulated	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
CsA	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
,	NULL
we	NULL
observed	NULL
either	NULL
limited	NULL
IL-2	NULL
production	NULL
using	NULL
ligand	NULL
or	NULL
CsA-sensitive	NULL
IL-2	NULL
production	NULL
from	NULL
cross-linked	NULL
Ab	NULL
.	NULL

There	NULL
are	NULL
several	NULL
possible	NULL
explanations	NULL
for	NULL
this	NULL
.	NULL

One	NULL
possibility	NULL
may	NULL
be	NULL
that	NULL
mRNA	NULL
analysis	NULL
by	NULL
Northern	NULL
blotting	NULL
does	NULL
not	NULL
correlate	NULL
well	NULL
with	NULL
actual	NULL
IL-2	NULL
production	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
ELISA	NULL
.	NULL

A	NULL
second	NULL
alternative	NULL
is	NULL
that	NULL
their	NULL
autoradiographic	NULL
exposures	NULL
were	NULL
nonlinear	NULL
,	NULL
resulting	NULL
in	NULL
possible	NULL
differences	NULL
not	NULL
being	NULL
detected	NULL
.	NULL

A	NULL
third	NULL
possibility	NULL
is	NULL
that	NULL
there	NULL
are	NULL
genuine	NULL
differences	NULL
between	NULL
Ab	NULL
and	NULL
ligand	NULL
stimulation	NULL
of	NULL
this	NULL
pathway	NULL
;	NULL
indeed	NULL
,	NULL
several	NULL
differences	NULL
have	NULL
been	NULL
previously	NULL
reported	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
however	NULL
,	NULL
despite	NULL
these	NULL
differences	NULL
,	NULL
consistent	NULL
concepts	NULL
do	NULL
emerge	NULL
from	NULL
these	NULL
various	NULL
studies	NULL
.	NULL

Clearly	NULL
much	NULL
,	NULL
if	NULL
not	NULL
all	NULL
,	NULL
of	NULL
the	NULL
CD28	NULL
pathway	NULL
is	NULL
unaffected	NULL
by	NULL
CsA	NULL
,	NULL
and	NULL
in	NULL
all	NULL
studies	NULL
T	NULL
cell	NULL
proliferation	NULL
is	NULL
not	NULL
inhibited	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
calcium	NULL
signaling	NULL
,	NULL
as	NULL
seen	NULL
using	NULL
PMA	NULL
and	NULL
CD80	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
IL-2	NULL
induction	NULL
was	NULL
significantly	NULL
impaired	NULL
.	NULL

However	NULL
,	NULL
IL-2	NULL
production	NULL
generated	NULL
by	NULL
Ab	NULL
cross-linking	NULL
appears	NULL
to	NULL
be	NULL
sensitive	NULL
to	NULL
CsA	NULL
,	NULL
in	NULL
keeping	NULL
with	NULL
the	NULL
known	NULL
effects	NULL
of	NULL
calcium	NULL
stimulation	NULL
on	NULL
NF-AT	NULL
.	NULL

Nonetheless	NULL
,	NULL
a	NULL
residual	NULL
CsA-resistant	NULL
IL-2	NULL
signal	NULL
was	NULL
detected	NULL
using	NULL
Ab	NULL
stimulation	NULL
.	NULL

Overall	NULL
,	NULL
our	NULL
interpretation	NULL
of	NULL
these	NULL
various	NULL
data	NULL
is	NULL
that	NULL
the	NULL
CsA	NULL
resistance	NULL
associated	NULL
with	NULL
CD28	NULL
costimulation	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
IL-2	NULL
production	NULL
is	NULL
unaffected	NULL
by	NULL
CsA	NULL
but	NULL
that	NULL
the	NULL
CD28	NULL
pathway	NULL
responsible	NULL
for	NULL
costimulation	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
is	NULL
unaffected	NULL
and	NULL
may	NULL
ultimately	NULL
be	NULL
IL-2	NULL
independent	NULL
.	NULL

Our	NULL
findings	NULL
at	NULL
the	NULL
functional	NULL
level	NULL
are	NULL
supported	NULL
by	NULL
luciferase	NULL
assays	NULL
of	NULL
IL-2	NULL
gene	NULL
transcriptional	NULL
activation	NULL
.	NULL

These	NULL
demonstrated	NULL
that	NULL
both	NULL
NFE-AT	NULL
and	NULL
intact	NULL
IL-2	NULL
promoter	NULL
responses	NULL
were	NULL
either	NULL
not	NULL
stimulated	NULL
by	NULL
CD80	NULL
or	NULL
stimulated	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
was	NULL
CsA	NULL
sensitive	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

While	NULL
there	NULL
are	NULL
reports	NULL
that	NULL
suggest	NULL
an	NULL
NF-AT	NULL
response	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
(	NULL
29	NULL
)	NULL
,	NULL
these	NULL
clearly	NULL
represented	NULL
only	NULL
a	NULL
minor	NULL
fraction	NULL
of	NULL
NE-AT	NULL
activation	NULL
and	NULL
were	NULL
observed	NULL
using	NULL
anti-CD28	NULL
Abs	NULL
.	NULL

Thus	NULL
,	NULL
whereas	NULL
it	NULL
is	NULL
possible	NULL
using	NULL
Abs	NULL
to	NULL
detect	NULL
CsA-resistant	NULL
NF-AT	NULL
and	NULL
IL-2	NULL
responses	NULL
,	NULL
these	NULL
are	NULL
not	NULL
easily	NULL
observed	NULL
using	NULL
natural	NULL
ligands	NULL
.	NULL

In	NULL
comparing	NULL
CD28	NULL
Abs	NULL
and	NULL
CD80	NULL
ligands	NULL
directly	NULL
in	NULL
luciferase	NULL
assays	NULL
in	NULL
Jurkats	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
cross-linked	NULL
anti-CD28	NULL
stimulated	NULL
NF-AT	NULL
and	NULL
IL-2	NULL
luciferase	NULL
activity	NULL
to	NULL
a	NULL
greater	NULL
degree	NULL
than	NULL
either	NULL
soluble	NULL
anti-CD28	NULL
or	NULL
the	NULL
CD80	NULL
ligand	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
data	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
which	NULL
demonstrated	NULL
similar	NULL
differences	NULL
between	NULL
anti-CD28	NULL
and	NULL
CD80	NULL
ligand	NULL
in	NULL
IL-2	NULL
production	NULL
by	NULL
normal	NULL
T	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
support	NULL
the	NULL
view	NULL
that	NULL
cross-linked	NULL
CD28	NULL
Abs	NULL
are	NULL
significantly	NULL
more	NULL
potent	NULL
stimuli	NULL
for	NULL
IL-2	NULL
production	NULL
than	NULL
the	NULL
natural	NULL
ligand	NULL
under	NULL
some	NULL
conditions	NULL
of	NULL
T	NULL
cell	NULL
stimulation	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
NF-AT	NULL
and	NULL
IL-2	NULL
promoter	NULL
,	NULL
we	NULL
observed	NULL
CD80	NULL
stimulation	NULL
of	NULL
NFxB	NULL
and	NULL
AP-1-driven	NULL
luciferase	NULL
reporters	NULL
in	NULL
keeping	NULL
with	NULL
other	NULL
studies	NULL
implicating	NULL
CD28	NULL
in	NULL
AP-1	NULL
and	NULL
NFkB	NULL
signaling	NULL
(	NULL
12	NULL
,	NULL
23	NULL
,	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
we	NULL
could	NULL
only	NULL
observe	NULL
substantial	NULL
effects	NULL
on	NULL
IL-2	NULL
luciferase	NULL
by	NULL
CD80	NULL
ligation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PI	NULL
stimulation	NULL
.	NULL

Given	NULL
that	NULL
CD80	NULL
was	NULL
ineffective	NULL
with	NULL
PMA	NULL
1815	NULL
alone	NULL
,	NULL
this	NULL
suggests	NULL
that	NULL
CD28	NULL
signals	NULL
are	NULL
effective	NULL
on	NULL
the	NULL
whole	NULL
IL-2	NULL
promoter	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
calcium-dependent	NULL
stim-ulus	NULL
.	NULL

These	NULL
results	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
a	NULL
possible	NULL
effect	NULL
of	NULL
CD28-stabilizing	NULL
mRNA	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
apparent	NULL
discrepancy	NULL
between	NULL
proliferation	NULL
and	NULL
IL-2	NULL
production	NULL
,	NULL
we	NULL
investigated	NULL
directly	NULL
the	NULL
influence	NULL
of	NULL
IL-2	NULL
on	NULL
PMA	NULL
and	NULL
CD80	NULL
stimulation	NULL
.	NULL

Here	NULL
again	NULL
,	NULL
our	NULL
findings	NULL
supported	NULL
the	NULL
view	NULL
that	NULL
IL-2	NULL
was	NULL
not	NULL
critical	NULL
to	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
this	NULL
model	NULL
.	NULL

Strikingly	NULL
,	NULL
neither	NULL
anti-IL-2	NULL
nor	NULL
anti-IL2R	NULL
Abs	NULL
could	NULL
inhibit	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
indicating	NULL
that	NULL
IL-2	NULL
was	NULL
not	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
proliferation	NULL
driven	NULL
by	NULL
PMA	NULL
and	NULL
CD80	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
these	NULL
Abs	NULL
were	NULL
able	NULL
to	NULL
significantly	NULL
inhibit	NULL
proliferation	NULL
by	NULL
CD3	NULL
and	NULL
CD80	NULL
and	NULL
P	NULL
+	NULL
I	NULL
.	NULL

Despite	NULL
these	NULL
surprising	NULL
findings	NULL
,	NULL
our	NULL
data	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
at	NULL
least	NULL
two	NULL
previous	NULL
studies	NULL
using	NULL
IL-2	NULL
knockout	NULL
mice	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
studies	NULL
by	NULL
Razi-Wolf	NULL
evaluated	NULL
the	NULL
effect	NULL
of	NULL
B7	NULL
costimulation	NULL
on	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
in	NULL
IL-2-deficient	NULL
mice	NULL
(	NULL
38	NULL
)	NULL
.	NULL

This	NULL
established	NULL
that	NULL
B7	NULL
costimulation	NULL
was	NULL
still	NULL
effective	NULL
,	NULL
and	NULL
furthermore	NULL
it	NULL
appeared	NULL
that	NULL
this	NULL
proliferation	NULL
was	NULL
independent	NULL
of	NULL
other	NULL
cytokines	NULL
,	NULL
including	NULL
IL-4	NULL
and	NULL
other	NULL
common	NULL
y-chain-utiliz-ing	NULL
cytokines	NULL
.	NULL

Our	NULL
own	NULL
preliminary	NULL
experiments	NULL
concur	NULL
with	NULL
this	NULL
finding	NULL
in	NULL
that	NULL
we	NULL
are	NULL
unable	NULL
to	NULL
detect	NULL
IL-4	NULL
by	NULL
RT-PCR	NULL
analysis	NULL
.	NULL

More	NULL
recently	NULL
similar	NULL
findings	NULL
were	NULL
reported	NULL
by	NULL
Khoruts	NULL
et	NULL
al	NULL
.	NULL

(	NULL
39	NULL
)	NULL
,	NULL
which	NULL
revealed	NULL
a	NULL
CD28-dependent	NULL
IL-2-independent	NULL
function	NULL
triggered	NULL
by	NULL
LPS	NULL
.	NULL

Thus	NULL
,	NULL
despite	NULL
our	NULL
use	NULL
of	NULL
nonphysiological	NULL
stimuli	NULL
to	NULL
reveal	NULL
a	NULL
discrete	NULL
CD28	NULL
function	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
this	NULL
model	NULL
is	NULL
very	NULL
similar	NULL
to	NULL
functions	NULL
of	NULL
CD28	NULL
seen	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
on	NULL
CD28	NULL
ligation	NULL
using	NULL
T	NULL
cell	NULL
blasts	NULL
.	NULL

Given	NULL
that	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
appears	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
in	NULL
mice	NULL
,	NULL
these	NULL
studies	NULL
may	NULL
provide	NULL
a	NULL
useful	NULL
and	NULL
manipulable	NULL
model	NULL
for	NULL
understanding	NULL
the	NULL
functional	NULL
behavior	NULL
of	NULL
T	NULL
cells	NULL
that	NULL
are	NULL
able	NULL
to	NULL
operate	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
and	NULL
in	NULL
which	NULL
the	NULL
negative	NULL
regulatory	NULL
influences	NULL
of	NULL
IL-2	NULL
may	NULL
be	NULL
studied	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
D.	NULL
Williams	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
luciferase	NULL
constructs	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Shahinian	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
Pfeffer	NULL
,	NULL
K.	NULL
P.	NULL
Lee	NULL
,	NULL
T.	NULL
M.	NULL
Kundig	NULL
,	NULL
K.	NULL
Kishihara	NULL
,	NULL
A.	NULL
Wakeham	NULL
,	NULL
K.	NULL
Kawai	NULL
,	NULL
P.	NULL
S.	NULL
Ohashi	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
T.	NULL
W.	NULL
Mak	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
T	NULL
cell	NULL
costimulatory	NULL
requirements	NULL
in	NULL
CD28	NULL
deficient	NULL
mice	NULL
.	NULL

Science	NULL
261:609	NULL
.	NULL

2	NULL
.	NULL

Sadlack	NULL
,	NULL
B.	NULL
,	NULL
H.	NULL
Merz	NULL
,	NULL
H.	NULL
Schorle	NULL
,	NULL
A.	NULL
Schimple	NULL
,	NULL
A.	NULL
Feller	NULL
,	NULL
and	NULL
I.	NULL
Horak	NULL
.	NULL

1993	NULL
.	NULL

Ulcerative	NULL
colitis-like	NULL
disease	NULL
in	NULL
mice	NULL
with	NULL
a	NULL
disrupted	NULL
interleukin-2	NULL
gene	NULL
.	NULL

Cell	NULL
75:253	NULL
.	NULL

3	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
,	NULL
L.	NULL
M	NULL
Nadler	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
B7	NULL
and	NULL
CD28	NULL
receptor	NULL
families	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:321	NULL
.	NULL

4	NULL
.	NULL

Harding	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
G.	NULL
McArthur	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Gross	NULL
,	NULL
D.	NULL
H.	NULL
Raulet	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Allison	NULL
.	NULL

1992	NULL
.	NULL

CD28-mediated	NULL
signalling	NULL
co-stimulates	NULL
murine	NULL
T	NULL
cells	NULL
and	NULL
prevents	NULL
the	NULL
induction	NULL
of	NULL
anergy	NULL
in	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

Nature	NULL
356:607	NULL
.	NULL

5	NULL
.	NULL

Jenkins	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
P.	NULL
S.	NULL
Taylor	NULL
,	NULL
S.	NULL
D.	NULL
Norton	NULL
,	NULL
and	NULL
K.	NULL
B.	NULL
Urdahl	NULL
.	NULL

1991	NULL
.	NULL

CD28	NULL
delivers	NULL
a	NULL
costimulatory	NULL
signal	NULL
involved	NULL
in	NULL
antigen	NULL
specific	NULL
IL-2	NULL
production	NULL
by	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:2461	NULL
.	NULL

6	NULL
.	NULL

Tan	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
Anasetti	NULL
,	NULL
J.	NULL
Hansen	NULL
,	NULL
J.	NULL
Melrose	NULL
,	NULL
M.	NULL
Brunvand	NULL
,	NULL
J.	NULL
Bradshaw	NULL
,	NULL
J.	NULL
Ledbetter	NULL
,	NULL
and	NULL
P.	NULL
Linsley	NULL
.	NULL

1993	NULL
.	NULL

Induction	NULL
of	NULL
alloantigen	NULL
specific	NULL
hyporespon-siveness	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
by	NULL
blocking	NULL
interaction	NULL
of	NULL
CD28	NULL
with	NULL
its	NULL
natural	NULL
ligand	NULL
B7/BB1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:165	NULL
.	NULL

7	NULL
.	NULL

Linsley	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
J.	NULL
Ledbetter	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
CD28	NULL
receptor	NULL
during	NULL
T	NULL
cell	NULL
responses	NULL
to	NULL
antigen	NULL
.	NULL

Armu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:191	NULL
.	NULL

8	NULL
.	NULL

Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Linsley	NULL
.	NULL

1992	NULL
.	NULL

CD28	NULL
receptor	NULL
cross-linking	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
PLC	NULL
y1	NULL
.	NULL

Adv	NULL
.	NULL

Exp	NULL
.	NULL

Med	NULL
.	NULL

Biol	NULL
.	NULL

323:23	NULL
.	NULL

9	NULL
.	NULL

Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
N.	NULL
A.	NULL
Clipstone	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
J.	NULL
P.	NULL
Northrop	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1996	NULL
.	NULL

Rapid	NULL
shuttling	NULL
of	NULL
NF-AT	NULL
in	NULL
discrimination	NULL
of	NULL
Ca2+	NULL
signals	NULL
and	NULL
immu-nosuppression	NULL
.	NULL

Nature	NULL
383:837	NULL
.	NULL

10	NULL
.	NULL

Ward	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Westwick	NULL
,	NULL
N.	NULL
Hall	NULL
,	NULL
and	NULL
D.	NULL
Sansom	NULL
.	NULL

1993	NULL
.	NULL

CD28	NULL
ligation	NULL
elevates	NULL
PidIns	NULL
(	NULL
3,4	NULL
)	NULL
P	NULL
;	NULL
and	NULL
PidIns	NULL
(	NULL
3,4,5	NULL
}	NULL
P	NULL
;	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23:2572	NULL
.	NULL

11	NULL
.	NULL

Ward	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
A.	NULL
Wilson	NULL
,	NULL
L.	NULL
Turner	NULL
,	NULL
J.	NULL
Westwick	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Sansom	NULL
.	NULL

1995	NULL
.	NULL

Inhibition	NULL
of	NULL
CD28-mediated	NULL
T	NULL
cell	NULL
costimulation	NULL
by	NULL
the	NULL
phosphoinositide	NULL
3-kinase	NULL
inhibitor	NULL
wortmannin	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:526	NULL
.	NULL

12	NULL
.	NULL

Edmead	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Y.	NULL
I.	NULL
Patel	NULL
,	NULL
A.	NULL
Wilson	NULL
,	NULL
G.	NULL
Boulougouris	NULL
,	NULL
N.	NULL
D.	NULL
Hall	NULL
,	NULL
S.	NULL
G.	NULL
Ward	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Sansom	NULL
.	NULL

1996	NULL
.	NULL

Induction	NULL
of	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
by	NULL
CD28	NULL
signalling	NULL
involves	NULL
both	NULL
PI-3	NULL
kinase	NULL
and	NULL
acidic	NULL
sphingomyelinase	NULL
signals	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

57	NULL
;	NULL
3290	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
1816	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

Pages	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
Ragueneau	NULL
,	NULL
R.	NULL
Rottapel	NULL
,	NULL
A.	NULL
Trunch	NULL
,	NULL
J.	NULL
Nunes	NULL
,	NULL
J.	NULL
Imbert	NULL
,	NULL
and	NULL
D.	NULL
Olive	NULL
.	NULL

1994	NULL
.	NULL

Binding	NULL
of	NULL
phosphatidylinostol-3-OH	NULL
kinase	NULL
to	NULL
CD28	NULL
is	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
signalling	NULL
.	NULL

Nature	NULL
369:327	NULL
.	NULL

Crooks	NULL
,	NULL
M.	NULL
E.	NULL
C.	NULL
,	NULL
D.	NULL
R.	NULL
Littman	NULL
,	NULL
R.	NULL
H.	NULL
Carter	NULL
,	NULL
D.	NULL
T.	NULL
Fearon	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
and	NULL
P.	NULL
H.	NULL
Stein	NULL
.	NULL

1995	NULL
.	NULL

CD28-mediated	NULL
costimulation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
phosphatidyl-inositol-3-kinase	NULL
association	NULL
and	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6820	NULL
.	NULL

Parry	NULL
,	NULL
R.	NULL
V.	NULL
,	NULL
K.	NULL
Reif	NULL
,	NULL
G.	NULL
Smith	NULL
,	NULL
D.	NULL
M.	NULL
Sansom	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Hemmings	NULL
,	NULL
and	NULL
S.	NULL
G.	NULL
Ward	NULL
.	NULL

1997	NULL
.	NULL

Ligation	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
co-stimulatory	NULL
receptor	NULL
CD28	NULL
activates	NULL
the	NULL
serine-threonine	NULL
protein	NULL
kinase	NULL
protein	NULL
kinase	NULL
B.	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:2495	NULL
.	NULL

Franke	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
S.	NULL
Yang	NULL
,	NULL
T.	NULL
O.	NULL
Chan	NULL
,	NULL
K.	NULL
Datta	NULL
,	NULL
A.	NULL
Kazlauskas	NULL
,	NULL
D.	NULL
K.	NULL
Morrison	NULL
,	NULL
D.	NULL
R.	NULL
Kaplan	NULL
,	NULL
and	NULL
P.	NULL
N.	NULL
Tsichlis	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
protein	NULL
kinase	NULL
encoded	NULL
by	NULL
the	NULL
Akt	NULL
proto-oncogene	NULL
is	NULL
a	NULL
target	NULL
of	NULL
the	NULL
PDGF-activated	NULL
phosphoinositol	NULL
3-kinase	NULL
.	NULL

Cell	NULL
81:727	NULL
.	NULL

Pai	NULL
,	NULL
S.	NULL
,	NULL
V.	NULL
Calvo	NULL
,	NULL
M.	NULL
Wood	NULL
,	NULL
and	NULL
B.	NULL
E.	NULL
Bierer	NULL
.	NULL

1994	NULL
.	NULL

Cross-linking	NULL
CD28	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
70-kDa	NULL
S6	NULL
kinase	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24:2364	NULL
.	NULL

Cefai	NULL
,	NULL
D.	NULL
,	NULL
H.	NULL
Schneider	NULL
,	NULL
O.	NULL
Matangkasombut	NULL
,	NULL
H.	NULL
Kang	NULL
,	NULL
J.	NULL
Brody	NULL
,	NULL
and	NULL
C.	NULL
E.	NULL
Rudd	NULL
.	NULL

1998	NULL
.	NULL

CD28	NULL
receptor	NULL
endocytosis	NULL
is	NULL
targeted	NULL
by	NULL
mutations	NULL
that	NULL
disrupt	NULL
phospha-tidylinositol	NULL
3-kinase	NULL
binding	NULL
and	NULL
costimulation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:2223	NULL
.	NULL

McLeod	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
L.	NULL
S.	NULL
K.	NULL
Walker	NULL
,	NULL
C.	NULL
Ellwood	NULL
,	NULL
Y.	NULL
I.	NULL
Patel	NULL
,	NULL
G.	NULL
Boulougouris	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Sansom	NULL
.	NULL

1998	NULL
.	NULL

Activation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
with	NULL
superantigen	NULL
and	NULL
CD28	NULL
confers	NULL
resistance	NULL
to	NULL
apoptosis	NULL
by	NULL
CD95	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:2072	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
A.	NULL
J.	NULL
Minn	NULL
,	NULL
P.	NULL
J.	NULL
Noel	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
M.	NULL
A.	NULL
Accaviti	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1995	NULL
.	NULL

CD28	NULL
costimulation	NULL
can	NULL
promote	NULL
T	NULL
cell	NULL
survival	NULL
by	NULL
enhancing	NULL
expression	NULL
of	NULL
Bcl-X	NULL
;	NULL
,	NULL
.	NULL

Immunity	NULL
3:87	NULL
.	NULL

Noel	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
L.	NULL
H.	NULL
Boise	NULL
,	NULL
J.	NULL
M.	NULL
Green	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1996	NULL
.	NULL

CD28	NULL
costimulation	NULL
prevents	NULL
cell	NULL
death	NULL
during	NULL
primary	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:636	NULL
.	NULL

Lucas	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
I.	NULL
Negishi	NULL
,	NULL
K.	NULL
Nakayama	NULL
,	NULL
L.	NULL
E.	NULL
Fields	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Loh	NULL
.	NULL

1995	NULL
.	NULL

Naive	NULL
CD28	NULL
deficient	NULL
T	NULL
cells	NULL
can	NULL
initiate	NULL
but	NULL
not	NULL
sustain	NULL
an	NULL
in	NULL
vitro	NULL
antigen	NULL
specific	NULL
immune	NULL
response	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:5757	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727	NULL
.	NULL

Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
Northrop	NULL
,	NULL
C.	NULL
L.	NULL
Verweij	NULL
,	NULL
and	NULL
G.	NULL
R	NULL
Crabtree	NULL
.	NULL

1990	NULL
.	NULL

Transmission	NULL
of	NULL
signals	NULL
from	NULL
the	NULL
T	NULL
lymphocyte	NULL
antigen	NULL
receptor	NULL
to	NULL
the	NULL
genes	NULL
responsible	NULL
for	NULL
cell	NULL
proliferation	NULL
and	NULL
immune	NULL
function	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:421	NULL
.	NULL

Sansom	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
A.	NULL
Wilson	NULL
,	NULL
M.	NULL
Boshell	NULL
,	NULL
J.	NULL
Lewis	NULL
,	NULL
and	NULL
N.	NULL
D	NULL
Hall	NULL
.	NULL

1993	NULL
.	NULL

B7/CD28	NULL
but	NULL
not	NULL
LFA-3	NULL
CD2	NULL
interactions	NULL
can	NULL
provide	NULL
third	NULL
party	NULL
costimulation	NULL
for	NULL
human	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Immunology	NULL
80:242	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

IL-2-INDEPENDENT	NULL
T	NULL
CELL	NULL
PROLIFERATION	NULL
Williams	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
Woodrow	NULL
,	NULL
D.	NULL
Cantrell	NULL
,	NULL
and	NULL
E.	NULL
Murray	NULL
.	NULL

1995	NULL
.	NULL

PKC	NULL
is	NULL
not	NULL
a	NULL
downstream	NULL
effector	NULL
of	NULL
p21ras	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:42	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
M.	NULL
M.	NULL
Gillespie	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1987	NULL
.	NULL

T	NULL
cell	NULL
proliferation	NULL
involving	NULL
the	NULL
CD28	NULL
pathway	NULL
is	NULL
associated	NULL
with	NULL
cyclos-porine-resistant	NULL
interleukin	NULL
2	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:4472	NULL
.	NULL

Linsley	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Bradshaw	NULL
,	NULL
M.	NULL
Urnes	NULL
,	NULL
L.	NULL
Grosmaire	NULL
,	NULL
and	NULL
J.	NULL
Ledbetter	NULL
.	NULL

1993	NULL
.	NULL

CD28	NULL
engagement	NULL
by	NULL
B7/BB1	NULL
induces	NULL
transient	NULL
down-regulation	NULL
of	NULL
CD28	NULL
synthesis	NULL
and	NULL
prolonged	NULL
unresponsiveness	NULL
to	NULL
CD28	NULL
signalling	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:3161	NULL
.	NULL

Ghosh	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
M.	NULL
Cippitelli	NULL
,	NULL
J.	NULL
Subleski	NULL
,	NULL
R.	NULL
Lahesmaa	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T-cells	NULL
in	NULL
a	NULL
cyclosporin	NULL
A-resistant	NULL
pathway	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
271:7700	NULL
.	NULL

Lyons	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
Parish	NULL
.	NULL

1994	NULL
.	NULL

Determination	NULL
of	NULL
lymphocyte	NULL
division	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
171:131	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
McCaffrey	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
T.	NULL
Kerppola	NULL
,	NULL
J.	NULL
Lambert	NULL
,	NULL
G.	NULL
Verdine	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NF-ATp	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
and	NULL
interacts	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
365:352	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Perrino	NULL
,	NULL
T.	NULL
R.	NULL
Soderling	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

NF-ATp	NULL
a	NULL
T	NULL
lymphocyte	NULL
DNA	NULL
binding	NULL
protein	NULL
that	NULL
is	NULL
a	NULL
target	NULL
for	NULL
calcineurin	NULL
and	NULL
immuno-suppressive	NULL
drugs	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:3747	NULL
.	NULL

Nunes	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Y.	NULL
Collette	NULL
,	NULL
A.	NULL
Trunch	NULL
,	NULL
D.	NULL
Olive	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
p21	NULL
``	NULL
**	NULL
in	NULL
€D28	NULL
signal	NULL
transduction	NULL
:	NULL
triggering	NULL
of	NULL
CD28	NULL
with	NULL
antibodies	NULL
but	NULL
not	NULL
the	NULL
B7-1	NULL
ligand	NULL
activates	NULL
p21	NULL
``	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1067	NULL
.	NULL

Hughes	NULL
,	NULL
C.	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Pober	NULL
.	NULL

1996	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:5369	NULL
.	NULL

Ghosh	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
Tan	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
and	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
interleukin	NULL
2	NULL
CD28-responsive	NULL
complex	NULL
contains	NULL
at	NULL
least	NULL
three	NULL
members	NULL
of	NULL
the	NULL
NF-kB	NULL
fam-ily	NULL
:	NULL
c-Rel	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p-65	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:1696	NULL
.	NULL

Lai	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Tan	NULL
.	NULL

1994	NULL
.	NULL

CD28	NULL
signaling	NULL
causes	NULL
a	NULL
sustained	NULL
down-regulation	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
which	NULL
can	NULL
be	NULL
prevented	NULL
by	NULL
the	NULL
immunosuppressant	NULL
rapamycin	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:30077	NULL
.	NULL

Lindsten	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
G.	NULL
Stella	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thomson	NULL
.	NULL

1989	NULL
.	NULL

Regulation	NULL
of	NULL
lymphokine	NULL
messenger	NULL
RNA	NULL
stability	NULL
by	NULL
a	NULL
surface-mediated	NULL
T	NULL
cell	NULL
activation	NULL
pathway	NULL
.	NULL

Science	NULL
244:339	NULL
.	NULL

Raziwolf	NULL
,	NULL
Z.	NULL
,	NULL
G.	NULL
A.	NULL
Hollander	NULL
,	NULL
and	NULL
H.	NULL
Reiser	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
CD4	NULL
(	NULL
+	NULL
)	NULL
T-lymphocytes	NULL
from	NULL
interleukin	NULL
2-deficient	NULL
mice	NULL
by	NULL
costimulatory	NULL
B7	NULL
molecules	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:2903	NULL
.	NULL

Khoruts	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Mondino	NULL
,	NULL
K.	NULL
A.	NULL
Pape	NULL
,	NULL
S.	NULL
L.	NULL
Reiner	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Jenkins	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
natural	NULL
immunological	NULL
adjuvant	NULL
enhances	NULL
T	NULL
cell	NULL
clonal	NULL
expansion	NULL
through	NULL
a	NULL
CD28-dependent	NULL
,	NULL
interleukin-2-independent	NULL
mechanism	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
187:225	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

